<?xml version='1.0' encoding='UTF-8'?>
<uniprot xmlns="http://uniprot.org/uniprot" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://uniprot.org/uniprot http://www.uniprot.org/support/docs/uniprot.xsd">
<entry dataset="Swiss-Prot" created="1990-11-01" modified="2017-05-10" version="212">
<accession>P15056</accession>
<accession>A4D1T4</accession>
<accession>B6HY61</accession>
<accession>B6HY62</accession>
<accession>B6HY63</accession>
<accession>B6HY64</accession>
<accession>B6HY65</accession>
<accession>B6HY66</accession>
<accession>Q13878</accession>
<accession>Q3MIN6</accession>
<accession>Q9UDP8</accession>
<accession>Q9Y6T3</accession>
<name>BRAF_HUMAN</name>
<protein>
<recommendedName>
<fullName>Serine/threonine-protein kinase B-raf</fullName>
<ecNumber>2.7.11.1</ecNumber>
</recommendedName>
<alternativeName>
<fullName>Proto-oncogene B-Raf</fullName>
</alternativeName>
<alternativeName>
<fullName>p94</fullName>
</alternativeName>
<alternativeName>
<fullName>v-Raf murine sarcoma viral oncogene homolog B1</fullName>
</alternativeName>
</protein>
<gene>
<name type="primary">BRAF</name>
<name type="synonym">BRAF1</name>
<name type="synonym">RAFB1</name>
</gene>
<organism>
<name type="scientific">Homo sapiens</name>
<name type="common">Human</name>
<dbReference type="NCBI Taxonomy" id="9606"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Primates</taxon>
<taxon>Haplorrhini</taxon>
<taxon>Catarrhini</taxon>
<taxon>Hominidae</taxon>
<taxon>Homo</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="1992" name="Mol. Cell. Biol." volume="12" first="3733" last="3742">
<title>95-kilodalton B-Raf serine/threonine kinase: identification of the protein and its major autophosphorylation site.</title>
<authorList>
<person name="Stephens R.M."/>
<person name="Sithanandam G."/>
<person name="Copeland T.D."/>
<person name="Kaplan D.R."/>
<person name="Rapp U.R."/>
<person name="Morrison D.K."/>
</authorList>
<dbReference type="PubMed" id="1508179"/>
<dbReference type="DOI" id="10.1128/MCB.12.9.3733"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA]</scope>
<scope>PARTIAL PROTEIN SEQUENCE</scope>
<scope>PHOSPHORYLATION AT THR-373</scope>
<source>
<tissue>Testis</tissue>
</source>
</reference>
<reference key="2">
<citation type="submission" date="2004-01" db="EMBL/GenBank/DDBJ databases">
<authorList>
<person name="Albert S."/>
<person name="Wixler L."/>
<person name="Rapp U.R."/>
</authorList>
</citation>
<scope>SEQUENCE REVISION TO 31-33</scope>
</reference>
<reference key="3">
<citation type="submission" date="2008-03" db="EMBL/GenBank/DDBJ databases">
<authorList>
<consortium name="NIEHS SNPs program"/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA]</scope>
</reference>
<reference key="4">
<citation type="journal article" date="2003" name="Science" volume="300" first="767" last="772">
<title>Human chromosome 7: DNA sequence and biology.</title>
<authorList>
<person name="Scherer S.W."/>
<person name="Cheung J."/>
<person name="MacDonald J.R."/>
<person name="Osborne L.R."/>
<person name="Nakabayashi K."/>
<person name="Herbrick J.-A."/>
<person name="Carson A.R."/>
<person name="Parker-Katiraee L."/>
<person name="Skaug J."/>
<person name="Khaja R."/>
<person name="Zhang J."/>
<person name="Hudek A.K."/>
<person name="Li M."/>
<person name="Haddad M."/>
<person name="Duggan G.E."/>
<person name="Fernandez B.A."/>
<person name="Kanematsu E."/>
<person name="Gentles S."/>
<person name="Christopoulos C.C."/>
<person name="Choufani S."/>
<person name="Kwasnicka D."/>
<person name="Zheng X.H."/>
<person name="Lai Z."/>
<person name="Nusskern D.R."/>
<person name="Zhang Q."/>
<person name="Gu Z."/>
<person name="Lu F."/>
<person name="Zeesman S."/>
<person name="Nowaczyk M.J."/>
<person name="Teshima I."/>
<person name="Chitayat D."/>
<person name="Shuman C."/>
<person name="Weksberg R."/>
<person name="Zackai E.H."/>
<person name="Grebe T.A."/>
<person name="Cox S.R."/>
<person name="Kirkpatrick S.J."/>
<person name="Rahman N."/>
<person name="Friedman J.M."/>
<person name="Heng H.H.Q."/>
<person name="Pelicci P.G."/>
<person name="Lo-Coco F."/>
<person name="Belloni E."/>
<person name="Shaffer L.G."/>
<person name="Pober B."/>
<person name="Morton C.C."/>
<person name="Gusella J.F."/>
<person name="Bruns G.A.P."/>
<person name="Korf B.R."/>
<person name="Quade B.J."/>
<person name="Ligon A.H."/>
<person name="Ferguson H."/>
<person name="Higgins A.W."/>
<person name="Leach N.T."/>
<person name="Herrick S.R."/>
<person name="Lemyre E."/>
<person name="Farra C.G."/>
<person name="Kim H.-G."/>
<person name="Summers A.M."/>
<person name="Gripp K.W."/>
<person name="Roberts W."/>
<person name="Szatmari P."/>
<person name="Winsor E.J.T."/>
<person name="Grzeschik K.-H."/>
<person name="Teebi A."/>
<person name="Minassian B.A."/>
<person name="Kere J."/>
<person name="Armengol L."/>
<person name="Pujana M.A."/>
<person name="Estivill X."/>
<person name="Wilson M.D."/>
<person name="Koop B.F."/>
<person name="Tosi S."/>
<person name="Moore G.E."/>
<person name="Boright A.P."/>
<person name="Zlotorynski E."/>
<person name="Kerem B."/>
<person name="Kroisel P.M."/>
<person name="Petek E."/>
<person name="Oscier D.G."/>
<person name="Mould S.J."/>
<person name="Doehner H."/>
<person name="Doehner K."/>
<person name="Rommens J.M."/>
<person name="Vincent J.B."/>
<person name="Venter J.C."/>
<person name="Li P.W."/>
<person name="Mural R.J."/>
<person name="Adams M.D."/>
<person name="Tsui L.-C."/>
</authorList>
<dbReference type="PubMed" id="12690205"/>
<dbReference type="DOI" id="10.1126/science.1083423"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="5">
<citation type="journal article" date="2003" name="Nature" volume="424" first="157" last="164">
<title>The DNA sequence of human chromosome 7.</title>
<authorList>
<person name="Hillier L.W."/>
<person name="Fulton R.S."/>
<person name="Fulton L.A."/>
<person name="Graves T.A."/>
<person name="Pepin K.H."/>
<person name="Wagner-McPherson C."/>
<person name="Layman D."/>
<person name="Maas J."/>
<person name="Jaeger S."/>
<person name="Walker R."/>
<person name="Wylie K."/>
<person name="Sekhon M."/>
<person name="Becker M.C."/>
<person name="O'Laughlin M.D."/>
<person name="Schaller M.E."/>
<person name="Fewell G.A."/>
<person name="Delehaunty K.D."/>
<person name="Miner T.L."/>
<person name="Nash W.E."/>
<person name="Cordes M."/>
<person name="Du H."/>
<person name="Sun H."/>
<person name="Edwards J."/>
<person name="Bradshaw-Cordum H."/>
<person name="Ali J."/>
<person name="Andrews S."/>
<person name="Isak A."/>
<person name="Vanbrunt A."/>
<person name="Nguyen C."/>
<person name="Du F."/>
<person name="Lamar B."/>
<person name="Courtney L."/>
<person name="Kalicki J."/>
<person name="Ozersky P."/>
<person name="Bielicki L."/>
<person name="Scott K."/>
<person name="Holmes A."/>
<person name="Harkins R."/>
<person name="Harris A."/>
<person name="Strong C.M."/>
<person name="Hou S."/>
<person name="Tomlinson C."/>
<person name="Dauphin-Kohlberg S."/>
<person name="Kozlowicz-Reilly A."/>
<person name="Leonard S."/>
<person name="Rohlfing T."/>
<person name="Rock S.M."/>
<person name="Tin-Wollam A.-M."/>
<person name="Abbott A."/>
<person name="Minx P."/>
<person name="Maupin R."/>
<person name="Strowmatt C."/>
<person name="Latreille P."/>
<person name="Miller N."/>
<person name="Johnson D."/>
<person name="Murray J."/>
<person name="Woessner J.P."/>
<person name="Wendl M.C."/>
<person name="Yang S.-P."/>
<person name="Schultz B.R."/>
<person name="Wallis J.W."/>
<person name="Spieth J."/>
<person name="Bieri T.A."/>
<person name="Nelson J.O."/>
<person name="Berkowicz N."/>
<person name="Wohldmann P.E."/>
<person name="Cook L.L."/>
<person name="Hickenbotham M.T."/>
<person name="Eldred J."/>
<person name="Williams D."/>
<person name="Bedell J.A."/>
<person name="Mardis E.R."/>
<person name="Clifton S.W."/>
<person name="Chissoe S.L."/>
<person name="Marra M.A."/>
<person name="Raymond C."/>
<person name="Haugen E."/>
<person name="Gillett W."/>
<person name="Zhou Y."/>
<person name="James R."/>
<person name="Phelps K."/>
<person name="Iadanoto S."/>
<person name="Bubb K."/>
<person name="Simms E."/>
<person name="Levy R."/>
<person name="Clendenning J."/>
<person name="Kaul R."/>
<person name="Kent W.J."/>
<person name="Furey T.S."/>
<person name="Baertsch R.A."/>
<person name="Brent M.R."/>
<person name="Keibler E."/>
<person name="Flicek P."/>
<person name="Bork P."/>
<person name="Suyama M."/>
<person name="Bailey J.A."/>
<person name="Portnoy M.E."/>
<person name="Torrents D."/>
<person name="Chinwalla A.T."/>
<person name="Gish W.R."/>
<person name="Eddy S.R."/>
<person name="McPherson J.D."/>
<person name="Olson M.V."/>
<person name="Eichler E.E."/>
<person name="Green E.D."/>
<person name="Waterston R.H."/>
<person name="Wilson R.K."/>
</authorList>
<dbReference type="PubMed" id="12853948"/>
<dbReference type="DOI" id="10.1038/nature01782"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="6">
<citation type="journal article" date="2004" name="Genome Res." volume="14" first="2121" last="2127">
<title>The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).</title>
<authorList>
<consortium name="The MGC Project Team"/>
</authorList>
<dbReference type="PubMed" id="15489334"/>
<dbReference type="DOI" id="10.1101/gr.2596504"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]</scope>
<source>
<tissue>Liver</tissue>
</source>
</reference>
<reference key="7">
<citation type="journal article" date="1992" name="Oncogene" volume="7" first="1657" last="1660">
<title>Chromosomal assignment of two human B-raf(Rmil) proto-oncogene loci: B-raf-1 encoding the p94Braf/Rmil and B-raf-2, a processed pseudogene.</title>
<authorList>
<person name="Eychene A."/>
<person name="Barnier J.V."/>
<person name="Apiou F."/>
<person name="Dutrillaux B."/>
<person name="Calothy G."/>
</authorList>
<dbReference type="PubMed" id="1630826"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-200</scope>
<source>
<tissue>Placenta</tissue>
</source>
</reference>
<reference key="8">
<citation type="submission" date="2008-12" db="UniProtKB">
<authorList>
<person name="Bienvenut W.V."/>
<person name="Boldt K."/>
<person name="von Kriegsheim A.F."/>
<person name="Zebisch A."/>
<person name="Kolch W."/>
</authorList>
</citation>
<scope>PROTEIN SEQUENCE OF 2-51; 56-95; 151-158; 189-199; 253-260; 294-354; 361-424; 444-507; 510-522; 559-570; 579-626; 663-680; 692-698; 702-719; 727-735 AND 753-766</scope>
<scope>CLEAVAGE OF INITIATOR METHIONINE</scope>
<scope>ACETYLATION AT ALA-2</scope>
<scope>PHOSPHORYLATION AT SER-365; THR-396; SER-399; THR-401 AND SER-729</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY</scope>
<source>
<tissue>Colon carcinoma</tissue>
<tissue>Hepatoma</tissue>
</source>
</reference>
<reference key="9">
<citation type="journal article" date="1990" name="Oncogene" volume="5" first="1775" last="1780">
<title>Complete coding sequence of a human B-raf cDNA and detection of B-raf protein kinase with isozyme specific antibodies.</title>
<authorList>
<person name="Sithanandam G."/>
<person name="Kolch W."/>
<person name="Duh F.-M."/>
<person name="Rapp U.R."/>
</authorList>
<dbReference type="PubMed" id="2284096"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] OF 117-766</scope>
<source>
<tissue>Testis</tissue>
</source>
</reference>
<reference key="10">
<citation type="journal article" date="2008" name="Cancer Res." volume="68" first="8673" last="8677">
<title>Tandem duplication producing a novel oncogenic BRAF fusion gene defines the majority of pilocytic astrocytomas.</title>
<authorList>
<person name="Jones D.T.W."/>
<person name="Kocialkowski S."/>
<person name="Liu L."/>
<person name="Pearson D.M."/>
<person name="Backlund L.M."/>
<person name="Ichimura K."/>
<person name="Collins V.P."/>
</authorList>
<dbReference type="PubMed" id="18974108"/>
<dbReference type="DOI" id="10.1158/0008-5472.CAN-08-2097"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] OF 381-766</scope>
<scope>DISEASE</scope>
<scope>CHROMOSOMAL REARRANGEMENT</scope>
<source>
<tissue>Brain</tissue>
</source>
</reference>
<reference key="11">
<citation type="journal article" date="1988" name="Mol. Cell. Biol." volume="8" first="2651" last="2654">
<title>B-raf, a new member of the raf family, is activated by DNA rearrangement.</title>
<authorList>
<person name="Ikawa S."/>
<person name="Fukui M."/>
<person name="Ueyama Y."/>
<person name="Tamaoki N."/>
<person name="Yamamoto T."/>
<person name="Toyoshima K."/>
</authorList>
<dbReference type="PubMed" id="3043188"/>
<dbReference type="DOI" id="10.1128/MCB.8.6.2651"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] OF 439-766</scope>
</reference>
<reference key="12">
<citation type="journal article" date="2001" name="J. Biol. Chem." volume="276" first="31620" last="31626">
<title>Serum- and glucocorticoid-inducible kinase SGK phosphorylates and negatively regulates B-Raf.</title>
<authorList>
<person name="Zhang B.H."/>
<person name="Tang E.D."/>
<person name="Zhu T."/>
<person name="Greenberg M.E."/>
<person name="Vojtek A.B."/>
<person name="Guan K.L."/>
</authorList>
<dbReference type="PubMed" id="11410590"/>
<dbReference type="DOI" id="10.1074/jbc.M102808200"/>
</citation>
<scope>PHOSPHORYLATION AT SER-365 BY SGK1</scope>
</reference>
<reference key="13">
<citation type="journal article" date="2006" name="Nat. Biotechnol." volume="24" first="1285" last="1292">
<title>A probability-based approach for high-throughput protein phosphorylation analysis and site localization.</title>
<authorList>
<person name="Beausoleil S.A."/>
<person name="Villen J."/>
<person name="Gerber S.A."/>
<person name="Rush J."/>
<person name="Gygi S.P."/>
</authorList>
<dbReference type="PubMed" id="16964243"/>
<dbReference type="DOI" id="10.1038/nbt1240"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-401</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="14">
<citation type="journal article" date="2008" name="Mol. Cell" volume="31" first="438" last="448">
<title>Kinase-selective enrichment enables quantitative phosphoproteomics of the kinome across the cell cycle.</title>
<authorList>
<person name="Daub H."/>
<person name="Olsen J.V."/>
<person name="Bairlein M."/>
<person name="Gnad F."/>
<person name="Oppermann F.S."/>
<person name="Korner R."/>
<person name="Greff Z."/>
<person name="Keri G."/>
<person name="Stemmann O."/>
<person name="Mann M."/>
</authorList>
<dbReference type="PubMed" id="18691976"/>
<dbReference type="DOI" id="10.1016/j.molcel.2008.07.007"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="15">
<citation type="journal article" date="2008" name="Proc. Natl. Acad. Sci. U.S.A." volume="105" first="10762" last="10767">
<title>A quantitative atlas of mitotic phosphorylation.</title>
<authorList>
<person name="Dephoure N."/>
<person name="Zhou C."/>
<person name="Villen J."/>
<person name="Beausoleil S.A."/>
<person name="Bakalarski C.E."/>
<person name="Elledge S.J."/>
<person name="Gygi S.P."/>
</authorList>
<dbReference type="PubMed" id="18669648"/>
<dbReference type="DOI" id="10.1073/pnas.0805139105"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-401; SER-446; SER-447 AND SER-729</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="16">
<citation type="journal article" date="2009" name="J. Biol. Chem." volume="284" first="29559" last="29570">
<title>Diacylglycerol kinase eta augments C-Raf activity and B-Raf/C-Raf heterodimerization.</title>
<authorList>
<person name="Yasuda S."/>
<person name="Kai M."/>
<person name="Imai S."/>
<person name="Takeishi K."/>
<person name="Taketomi A."/>
<person name="Toyota M."/>
<person name="Kanoh H."/>
<person name="Sakane F."/>
</authorList>
<dbReference type="PubMed" id="19710016"/>
<dbReference type="DOI" id="10.1074/jbc.M109.043604"/>
</citation>
<scope>SUBUNIT</scope>
<scope>INTERACTION WITH DGKH</scope>
<scope>PHOSPHORYLATION AT THR-753 BY MAPK1</scope>
</reference>
<reference key="17">
<citation type="journal article" date="2009" name="Sci. Signal." volume="2" first="RA46" last="RA46">
<title>Quantitative phosphoproteomic analysis of T cell receptor signaling reveals system-wide modulation of protein-protein interactions.</title>
<authorList>
<person name="Mayya V."/>
<person name="Lundgren D.H."/>
<person name="Hwang S.-I."/>
<person name="Rezaul K."/>
<person name="Wu L."/>
<person name="Eng J.K."/>
<person name="Rodionov V."/>
<person name="Han D.K."/>
</authorList>
<dbReference type="PubMed" id="19690332"/>
<dbReference type="DOI" id="10.1126/scisignal.2000007"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Leukemic T-cell</tissue>
</source>
</reference>
<reference key="18">
<citation type="journal article" date="2010" name="Nat. Cell Biol." volume="12" first="1242" last="1249">
<title>AKAP-Lbc enhances cyclic AMP control of the ERK1/2 cascade.</title>
<authorList>
<person name="Smith F.D."/>
<person name="Langeberg L.K."/>
<person name="Cellurale C."/>
<person name="Pawson T."/>
<person name="Morrison D.K."/>
<person name="Davis R.J."/>
<person name="Scott J.D."/>
</authorList>
<dbReference type="PubMed" id="21102438"/>
<dbReference type="DOI" id="10.1038/ncb2130"/>
</citation>
<scope>INTERACTION WITH AKAP13; MAP2K1 AND KSR1</scope>
</reference>
<reference key="19">
<citation type="journal article" date="2010" name="Sci. Signal." volume="3" first="RA3" last="RA3">
<title>Quantitative phosphoproteomics reveals widespread full phosphorylation site occupancy during mitosis.</title>
<authorList>
<person name="Olsen J.V."/>
<person name="Vermeulen M."/>
<person name="Santamaria A."/>
<person name="Kumar C."/>
<person name="Miller M.L."/>
<person name="Jensen L.J."/>
<person name="Gnad F."/>
<person name="Cox J."/>
<person name="Jensen T.S."/>
<person name="Nigg E.A."/>
<person name="Brunak S."/>
<person name="Mann M."/>
</authorList>
<dbReference type="PubMed" id="20068231"/>
<dbReference type="DOI" id="10.1126/scisignal.2000475"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="20">
<citation type="journal article" date="2011" name="Nature" volume="472" first="366" last="369">
<title>A Raf-induced allosteric transition of KSR stimulates phosphorylation of MEK.</title>
<authorList>
<person name="Brennan D.F."/>
<person name="Dar A.C."/>
<person name="Hertz N.T."/>
<person name="Chao W.C."/>
<person name="Burlingame A.L."/>
<person name="Shokat K.M."/>
<person name="Barford D."/>
</authorList>
<dbReference type="PubMed" id="21441910"/>
<dbReference type="DOI" id="10.1038/nature09860"/>
</citation>
<scope>INTERACTION WITH KSR2</scope>
<scope>SUBUNIT</scope>
<scope>CATALYTIC ACTIVITY</scope>
<scope>FUNCTION</scope>
<scope>MUTAGENESIS OF LYS-483</scope>
</reference>
<reference key="21">
<citation type="journal article" date="2011" name="Sci. Signal." volume="4" first="RA58" last="RA58">
<title>Protein arginine methyltransferase 5 regulates ERK1/2 signal transduction amplitude and cell fate through CRAF.</title>
<authorList>
<person name="Andreu-Perez P."/>
<person name="Esteve-Puig R."/>
<person name="de Torre-Minguela C."/>
<person name="Lopez-Fauqued M."/>
<person name="Bech-Serra J.J."/>
<person name="Tenbaum S."/>
<person name="Garcia-Trevijano E.R."/>
<person name="Canals F."/>
<person name="Merlino G."/>
<person name="Avila M.A."/>
<person name="Recio J.A."/>
</authorList>
<dbReference type="PubMed" id="21917714"/>
<dbReference type="DOI" id="10.1126/scisignal.2001936"/>
</citation>
<scope>INTERACTION WITH PRMT5</scope>
<scope>METHYLATION AT ARG-671</scope>
<scope>CHARACTERIZATION OF VARIANT CRC GLU-600</scope>
<scope>MUTAGENESIS OF ARG-671</scope>
</reference>
<reference key="22">
<citation type="journal article" date="2011" name="Sci. Signal." volume="4" first="RS3" last="RS3">
<title>System-wide temporal characterization of the proteome and phosphoproteome of human embryonic stem cell differentiation.</title>
<authorList>
<person name="Rigbolt K.T."/>
<person name="Prokhorova T.A."/>
<person name="Akimov V."/>
<person name="Henningsen J."/>
<person name="Johansen P.T."/>
<person name="Kratchmarova I."/>
<person name="Kassem M."/>
<person name="Mann M."/>
<person name="Olsen J.V."/>
<person name="Blagoev B."/>
</authorList>
<dbReference type="PubMed" id="21406692"/>
<dbReference type="DOI" id="10.1126/scisignal.2001570"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-729</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="23">
<citation type="journal article" date="2012" name="J. Biol. Chem." volume="287" first="24017" last="24025">
<title>Ring finger protein 149 is an E3 ubiquitin ligase active on wild-type v-Raf murine sarcoma viral oncogene homolog B1 (BRAF).</title>
<authorList>
<person name="Hong S.W."/>
<person name="Jin D.H."/>
<person name="Shin J.S."/>
<person name="Moon J.H."/>
<person name="Na Y.S."/>
<person name="Jung K.A."/>
<person name="Kim S.M."/>
<person name="Kim J.C."/>
<person name="Kim K.P."/>
<person name="Hong Y.S."/>
<person name="Lee J.L."/>
<person name="Choi E.K."/>
<person name="Lee J.S."/>
<person name="Kim T.W."/>
</authorList>
<dbReference type="PubMed" id="22628551"/>
<dbReference type="DOI" id="10.1074/jbc.M111.319822"/>
</citation>
<scope>UBIQUITINATION BY RNF149</scope>
</reference>
<reference key="24">
<citation type="journal article" date="2013" name="J. Proteome Res." volume="12" first="260" last="271">
<title>Toward a comprehensive characterization of a human cancer cell phosphoproteome.</title>
<authorList>
<person name="Zhou H."/>
<person name="Di Palma S."/>
<person name="Preisinger C."/>
<person name="Peng M."/>
<person name="Polat A.N."/>
<person name="Heck A.J."/>
<person name="Mohammed S."/>
</authorList>
<dbReference type="PubMed" id="23186163"/>
<dbReference type="DOI" id="10.1021/pr300630k"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-151; SER-365; THR-401; SER-446 AND SER-729</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
<tissue>Erythroleukemia</tissue>
</source>
</reference>
<reference key="25">
<citation type="journal article" date="2013" name="Sci. Rep." volume="3" first="2344" last="2344">
<title>Lys63-linked polyubiquitination of BRAF at lysine 578 is required for BRAF-mediated signaling.</title>
<authorList>
<person name="An L."/>
<person name="Jia W."/>
<person name="Yu Y."/>
<person name="Zou N."/>
<person name="Liang L."/>
<person name="Zhao Y."/>
<person name="Fan Y."/>
<person name="Cheng J."/>
<person name="Shi Z."/>
<person name="Xu G."/>
<person name="Li G."/>
<person name="Yang J."/>
<person name="Zhang H."/>
</authorList>
<dbReference type="PubMed" id="23907581"/>
<dbReference type="DOI" id="10.1038/srep02344"/>
</citation>
<scope>UBIQUITINATION AT LYS-578</scope>
<scope>MUTAGENESIS OF LYS-578</scope>
</reference>
<reference key="26">
<citation type="journal article" date="2014" name="J. Proteomics" volume="96" first="253" last="262">
<title>An enzyme assisted RP-RPLC approach for in-depth analysis of human liver phosphoproteome.</title>
<authorList>
<person name="Bian Y."/>
<person name="Song C."/>
<person name="Cheng K."/>
<person name="Dong M."/>
<person name="Wang F."/>
<person name="Huang J."/>
<person name="Sun D."/>
<person name="Wang L."/>
<person name="Ye M."/>
<person name="Zou H."/>
</authorList>
<dbReference type="PubMed" id="24275569"/>
<dbReference type="DOI" id="10.1016/j.jprot.2013.11.014"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-151</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Liver</tissue>
</source>
</reference>
<reference key="27">
<citation type="journal article" date="2016" name="Nat. Commun." volume="7" first="12037" last="12037">
<title>The FNIP co-chaperones decelerate the Hsp90 chaperone cycle and enhance drug binding.</title>
<authorList>
<person name="Woodford M.R."/>
<person name="Dunn D.M."/>
<person name="Blanden A.R."/>
<person name="Capriotti D."/>
<person name="Loiselle D."/>
<person name="Prodromou C."/>
<person name="Panaretou B."/>
<person name="Hughes P.F."/>
<person name="Smith A."/>
<person name="Ackerman W."/>
<person name="Haystead T.A."/>
<person name="Loh S.N."/>
<person name="Bourboulia D."/>
<person name="Schmidt L.S."/>
<person name="Marston Linehan W."/>
<person name="Bratslavsky G."/>
<person name="Mollapour M."/>
</authorList>
<dbReference type="PubMed" id="27353360"/>
<dbReference type="DOI" id="10.1038/ncomms12037"/>
</citation>
<scope>INTERACTION WITH FNIP1 AND FNIP2</scope>
</reference>
<reference key="28">
<citation type="journal article" date="2008" name="Proc. Natl. Acad. Sci. U.S.A." volume="105" first="3041" last="3046">
<title>Discovery of a selective inhibitor of oncogenic B-Raf kinase with potent antimelanoma activity.</title>
<authorList>
<person name="Tsai J."/>
<person name="Lee J.T."/>
<person name="Wang W."/>
<person name="Zhang J."/>
<person name="Cho H."/>
<person name="Mamo S."/>
<person name="Bremer R."/>
<person name="Gillette S."/>
<person name="Kong J."/>
<person name="Haass N.K."/>
<person name="Sproesser K."/>
<person name="Li L."/>
<person name="Smalley K.S."/>
<person name="Fong D."/>
<person name="Zhu Y.L."/>
<person name="Marimuthu A."/>
<person name="Nguyen H."/>
<person name="Lam B."/>
<person name="Liu J."/>
<person name="Cheung I."/>
<person name="Rice J."/>
<person name="Suzuki Y."/>
<person name="Luu C."/>
<person name="Settachatgul C."/>
<person name="Shellooe R."/>
<person name="Cantwell J."/>
<person name="Kim S.H."/>
<person name="Schlessinger J."/>
<person name="Zhang K.Y."/>
<person name="West B.L."/>
<person name="Powell B."/>
<person name="Habets G."/>
<person name="Zhang C."/>
<person name="Ibrahim P.N."/>
<person name="Hirth P."/>
<person name="Artis D.R."/>
<person name="Herlyn M."/>
<person name="Bollag G."/>
</authorList>
<dbReference type="PubMed" id="18287029"/>
<dbReference type="DOI" id="10.1073/pnas.0711741105"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.57 ANGSTROMS) OF 444-719 IN COMPLEX WITH INHIBITOR</scope>
</reference>
<reference key="29">
<citation type="journal article" date="2002" name="Cancer Res." volume="62" first="7001" last="7003">
<title>Missense mutations of the BRAF gene in human lung adenocarcinoma.</title>
<authorList>
<person name="Naoki K."/>
<person name="Chen T.-H."/>
<person name="Richards W.G."/>
<person name="Sugarbaker D.J."/>
<person name="Meyerson M."/>
</authorList>
<dbReference type="PubMed" id="12460919"/>
</citation>
<scope>VARIANTS LNCR VAL-466 AND ARG-597</scope>
</reference>
<reference key="30">
<citation type="journal article" date="2002" name="Nature" volume="417" first="949" last="954">
<title>Mutations of the BRAF gene in human cancer.</title>
<authorList>
<person name="Davies H."/>
<person name="Bignell G.R."/>
<person name="Cox C."/>
<person name="Stephens P."/>
<person name="Edkins S."/>
<person name="Clegg S."/>
<person name="Teague J."/>
<person name="Woffendin H."/>
<person name="Garnett M.J."/>
<person name="Bottomley W."/>
<person name="Davis N."/>
<person name="Dicks E."/>
<person name="Ewing R."/>
<person name="Floyd Y."/>
<person name="Gray K."/>
<person name="Hall S."/>
<person name="Hawes R."/>
<person name="Hughes J."/>
<person name="Kosmidou V."/>
<person name="Menzies A."/>
<person name="Mould C."/>
<person name="Parker A."/>
<person name="Stevens C."/>
<person name="Watt S."/>
<person name="Hooper S."/>
<person name="Wilson R."/>
<person name="Jayatilake H."/>
<person name="Gusterson B.A."/>
<person name="Cooper C."/>
<person name="Shipley J."/>
<person name="Hargrave D."/>
<person name="Pritchard-Jones K."/>
<person name="Maitland N."/>
<person name="Chenevix-Trench G."/>
<person name="Riggins G.J."/>
<person name="Bigner D.D."/>
<person name="Palmieri G."/>
<person name="Cossu A."/>
<person name="Flanagan A."/>
<person name="Nicholson A."/>
<person name="Ho J.W.C."/>
<person name="Leung S.Y."/>
<person name="Yuen S.T."/>
<person name="Weber B.L."/>
<person name="Seigler H.F."/>
<person name="Darrow T.L."/>
<person name="Paterson H."/>
<person name="Marais R."/>
<person name="Marshall C.J."/>
<person name="Wooster R."/>
<person name="Stratton M.R."/>
<person name="Futreal P.A."/>
</authorList>
<dbReference type="PubMed" id="12068308"/>
<dbReference type="DOI" id="10.1038/nature00766"/>
</citation>
<scope>VARIANTS CANCER GLU-464; VAL-464; ALA-466; GLU-466; VAL-466; ALA-469; GLU-469; LYS-586; LEU-595; ARG-596; ARG-597; VAL-597; GLU-600 AND ASP-600</scope>
<scope>CHARACTERIZATION OF VARIANTS CANCER VAL-464; ALA-469; VAL-597 AND GLU-600</scope>
</reference>
<reference key="31">
<citation type="journal article" date="2002" name="Nature" volume="418" first="934" last="934">
<title>Tumorigenesis: RAF/RAS oncogenes and mismatch-repair status.</title>
<authorList>
<person name="Rajagopalan H."/>
<person name="Bardelli A."/>
<person name="Lengauer C."/>
<person name="Kinzler K.W."/>
<person name="Vogelstein B."/>
<person name="Velculescu V.E."/>
</authorList>
<dbReference type="PubMed" id="12198537"/>
<dbReference type="DOI" id="10.1038/418934a"/>
</citation>
<scope>VARIANTS CRC ILE-462; SER-463; GLU-464; GLU-600 AND GLU-601</scope>
</reference>
<reference key="32">
<citation type="journal article" date="2003" name="Br. J. Cancer" volume="89" first="1958" last="1960">
<title>BRAF mutations in non-Hodgkin's lymphoma.</title>
<authorList>
<person name="Lee J.W."/>
<person name="Yoo N.J."/>
<person name="Soung Ark W.S."/>
<person name="Kim S.Y."/>
<person name="Lee J.H."/>
<person name="Park J.Y."/>
<person name="Cho Y.G."/>
<person name="Kim C.J."/>
<person name="Ko Y.H."/>
<person name="Kim S.H."/>
<person name="Nam S.W."/>
<person name="Lee J.Y."/>
<person name="Lee S.H."/>
</authorList>
<dbReference type="PubMed" id="14612909"/>
<dbReference type="DOI" id="10.1038/sj.bjc.6601371"/>
</citation>
<scope>VARIANTS NHL ALA-469; ARG-469 AND GLY-594</scope>
</reference>
<reference key="33">
<citation type="journal article" date="2003" name="Cancer Res." volume="63" first="5198" last="5202">
<title>Suppression of BRAF(V599E) in human melanoma abrogates transformation.</title>
<authorList>
<person name="Hingorani S.R."/>
<person name="Jacobetz M.A."/>
<person name="Robertson G.P."/>
<person name="Herlyn M."/>
<person name="Tuveson D.A."/>
</authorList>
<dbReference type="PubMed" id="14500344"/>
</citation>
<scope>CHARACTERIZATION OF VARIANT MELANOMA GLU-600</scope>
</reference>
<reference key="34">
<citation type="journal article" date="2006" name="Nat. Genet." volume="38" first="294" last="296">
<title>Germline KRAS and BRAF mutations in cardio-facio-cutaneous syndrome.</title>
<authorList>
<person name="Niihori T."/>
<person name="Aoki Y."/>
<person name="Narumi Y."/>
<person name="Neri G."/>
<person name="Cave H."/>
<person name="Verloes A."/>
<person name="Okamoto N."/>
<person name="Hennekam R.C.M."/>
<person name="Gillessen-Kaesbach G."/>
<person name="Wieczorek D."/>
<person name="Kavamura M.I."/>
<person name="Kurosawa K."/>
<person name="Ohashi H."/>
<person name="Wilson L."/>
<person name="Heron D."/>
<person name="Bonneau D."/>
<person name="Corona G."/>
<person name="Kaname T."/>
<person name="Naritomi K."/>
<person name="Baumann C."/>
<person name="Matsumoto N."/>
<person name="Kato K."/>
<person name="Kure S."/>
<person name="Matsubara Y."/>
</authorList>
<dbReference type="PubMed" id="16474404"/>
<dbReference type="DOI" id="10.1038/ng1749"/>
</citation>
<scope>VARIANTS CFC1 PRO-246; ARG-257; GLU-469; PHE-485; GLU-499; LYS-501; GLY-501 AND ASP-581</scope>
</reference>
<reference key="35">
<citation type="journal article" date="2006" name="Science" volume="314" first="268" last="274">
<title>The consensus coding sequences of human breast and colorectal cancers.</title>
<authorList>
<person name="Sjoeblom T."/>
<person name="Jones S."/>
<person name="Wood L.D."/>
<person name="Parsons D.W."/>
<person name="Lin J."/>
<person name="Barber T.D."/>
<person name="Mandelker D."/>
<person name="Leary R.J."/>
<person name="Ptak J."/>
<person name="Silliman N."/>
<person name="Szabo S."/>
<person name="Buckhaults P."/>
<person name="Farrell C."/>
<person name="Meeh P."/>
<person name="Markowitz S.D."/>
<person name="Willis J."/>
<person name="Dawson D."/>
<person name="Willson J.K.V."/>
<person name="Gazdar A.F."/>
<person name="Hartigan J."/>
<person name="Wu L."/>
<person name="Liu C."/>
<person name="Parmigiani G."/>
<person name="Park B.H."/>
<person name="Bachman K.E."/>
<person name="Papadopoulos N."/>
<person name="Vogelstein B."/>
<person name="Kinzler K.W."/>
<person name="Velculescu V.E."/>
</authorList>
<dbReference type="PubMed" id="16959974"/>
<dbReference type="DOI" id="10.1126/science.1133427"/>
</citation>
<scope>VARIANT [LARGE SCALE ANALYSIS] GLU-600</scope>
</reference>
<reference key="36">
<citation type="journal article" date="2006" name="Science" volume="311" first="1287" last="1290">
<title>Germline mutations in genes within the MAPK pathway cause cardio-facio-cutaneous syndrome.</title>
<authorList>
<person name="Rodriguez-Viciana P."/>
<person name="Tetsu O."/>
<person name="Tidyman W.E."/>
<person name="Estep A.L."/>
<person name="Conger B.A."/>
<person name="Cruz M.S."/>
<person name="McCormick F."/>
<person name="Rauen K.A."/>
</authorList>
<dbReference type="PubMed" id="16439621"/>
<dbReference type="DOI" id="10.1126/science.1124642"/>
</citation>
<scope>VARIANTS CFC1 ARG-257; ALA-467; SER-468; GLU-469; PHE-485; GLU-499; LYS-501; GLY-501; ASP-581; LEU-595 AND VAL-596</scope>
</reference>
<reference key="37">
<citation type="journal article" date="2007" name="Nature" volume="446" first="153" last="158">
<title>Patterns of somatic mutation in human cancer genomes.</title>
<authorList>
<person name="Greenman C."/>
<person name="Stephens P."/>
<person name="Smith R."/>
<person name="Dalgliesh G.L."/>
<person name="Hunter C."/>
<person name="Bignell G."/>
<person name="Davies H."/>
<person name="Teague J."/>
<person name="Butler A."/>
<person name="Stevens C."/>
<person name="Edkins S."/>
<person name="O'Meara S."/>
<person name="Vastrik I."/>
<person name="Schmidt E.E."/>
<person name="Avis T."/>
<person name="Barthorpe S."/>
<person name="Bhamra G."/>
<person name="Buck G."/>
<person name="Choudhury B."/>
<person name="Clements J."/>
<person name="Cole J."/>
<person name="Dicks E."/>
<person name="Forbes S."/>
<person name="Gray K."/>
<person name="Halliday K."/>
<person name="Harrison R."/>
<person name="Hills K."/>
<person name="Hinton J."/>
<person name="Jenkinson A."/>
<person name="Jones D."/>
<person name="Menzies A."/>
<person name="Mironenko T."/>
<person name="Perry J."/>
<person name="Raine K."/>
<person name="Richardson D."/>
<person name="Shepherd R."/>
<person name="Small A."/>
<person name="Tofts C."/>
<person name="Varian J."/>
<person name="Webb T."/>
<person name="West S."/>
<person name="Widaa S."/>
<person name="Yates A."/>
<person name="Cahill D.P."/>
<person name="Louis D.N."/>
<person name="Goldstraw P."/>
<person name="Nicholson A.G."/>
<person name="Brasseur F."/>
<person name="Looijenga L."/>
<person name="Weber B.L."/>
<person name="Chiew Y.-E."/>
<person name="DeFazio A."/>
<person name="Greaves M.F."/>
<person name="Green A.R."/>
<person name="Campbell P."/>
<person name="Birney E."/>
<person name="Easton D.F."/>
<person name="Chenevix-Trench G."/>
<person name="Tan M.-H."/>
<person name="Khoo S.K."/>
<person name="Teh B.T."/>
<person name="Yuen S.T."/>
<person name="Leung S.Y."/>
<person name="Wooster R."/>
<person name="Futreal P.A."/>
<person name="Stratton M.R."/>
</authorList>
<dbReference type="PubMed" id="17344846"/>
<dbReference type="DOI" id="10.1038/nature05610"/>
</citation>
<scope>VARIANTS [LARGE SCALE ANALYSIS] SER-301; ALA-469; VAL-469; SER-581; ARG-596; ARG-597; VAL-597 AND GLU-600</scope>
</reference>
<reference key="38">
<citation type="journal article" date="2008" name="Clin. Genet." volume="73" first="62" last="70">
<title>Mutation and phenotypic spectrum in patients with cardio-facio-cutaneous and Costello syndrome.</title>
<authorList>
<person name="Schulz A.L."/>
<person name="Albrecht B."/>
<person name="Arici C."/>
<person name="van der Burgt I."/>
<person name="Buske A."/>
<person name="Gillessen-Kaesbach G."/>
<person name="Heller R."/>
<person name="Horn D."/>
<person name="Hubner C.A."/>
<person name="Korenke G.C."/>
<person name="Konig R."/>
<person name="Kress W."/>
<person name="Kruger G."/>
<person name="Meinecke P."/>
<person name="Mucke J."/>
<person name="Plecko B."/>
<person name="Rossier E."/>
<person name="Schinzel A."/>
<person name="Schulze A."/>
<person name="Seemanova E."/>
<person name="Seidel H."/>
<person name="Spranger S."/>
<person name="Tuysuz B."/>
<person name="Uhrig S."/>
<person name="Wieczorek D."/>
<person name="Kutsche K."/>
<person name="Zenker M."/>
</authorList>
<dbReference type="PubMed" id="18042262"/>
<dbReference type="DOI" id="10.1111/j.1399-0004.2007.00931.x"/>
</citation>
<scope>VARIANTS CFC1 PRO-241; PRO-244; PRO-246; ARG-257; LYS-262; SER-468; GLU-469; GLU-499; ASN-499; ASP-580; ASP-581 AND LEU-595</scope>
</reference>
<reference key="39">
<citation type="journal article" date="2009" name="Hum. Mutat." volume="30" first="695" last="702">
<title>Germline BRAF mutations in Noonan, LEOPARD, and cardiofaciocutaneous syndromes: molecular diversity and associated phenotypic spectrum.</title>
<authorList>
<person name="Sarkozy A."/>
<person name="Carta C."/>
<person name="Moretti S."/>
<person name="Zampino G."/>
<person name="Digilio M.C."/>
<person name="Pantaleoni F."/>
<person name="Scioletti A.P."/>
<person name="Esposito G."/>
<person name="Cordeddu V."/>
<person name="Lepri F."/>
<person name="Petrangeli V."/>
<person name="Dentici M.L."/>
<person name="Mancini G.M."/>
<person name="Selicorni A."/>
<person name="Rossi C."/>
<person name="Mazzanti L."/>
<person name="Marino B."/>
<person name="Ferrero G.B."/>
<person name="Silengo M.C."/>
<person name="Memo L."/>
<person name="Stanzial F."/>
<person name="Faravelli F."/>
<person name="Stuppia L."/>
<person name="Puxeddu E."/>
<person name="Gelb B.D."/>
<person name="Dallapiccola B."/>
<person name="Tartaglia M."/>
</authorList>
<dbReference type="PubMed" id="19206169"/>
<dbReference type="DOI" id="10.1002/humu.20955"/>
</citation>
<scope>VARIANT LPRD3 PRO-241</scope>
<scope>VARIANTS NS7 CYS-531 AND VAL-597</scope>
<scope>VARIANTS CFC1 PHE-245; PRO-246; ARG-257; LYS-275; GLU-469; PHE-485; ASN-499; LYS-501; PRO-525; LEU-595; ARG-599; GLN-601; GLU-638 AND ARG-709</scope>
<scope>VARIANTS ARG-241 AND MET-241</scope>
</reference>
<reference key="40">
<citation type="journal article" date="2013" name="Nat. Genet." volume="45" first="136" last="144">
<title>Germline mutations affecting the proofreading domains of POLE and POLD1 predispose to colorectal adenomas and carcinomas.</title>
<authorList>
<consortium name="CORGI Consortium"/>
<consortium name="WGS500 Consortium"/>
<person name="Palles C."/>
<person name="Cazier J.B."/>
<person name="Howarth K.M."/>
<person name="Domingo E."/>
<person name="Jones A.M."/>
<person name="Broderick P."/>
<person name="Kemp Z."/>
<person name="Spain S.L."/>
<person name="Guarino Almeida E."/>
<person name="Salguero I."/>
<person name="Sherborne A."/>
<person name="Chubb D."/>
<person name="Carvajal-Carmona L.G."/>
<person name="Ma Y."/>
<person name="Kaur K."/>
<person name="Dobbins S."/>
<person name="Barclay E."/>
<person name="Gorman M."/>
<person name="Martin L."/>
<person name="Kovac M.B."/>
<person name="Humphray S."/>
<person name="Lucassen A."/>
<person name="Holmes C.C."/>
<person name="Bentley D."/>
<person name="Donnelly P."/>
<person name="Taylor J."/>
<person name="Petridis C."/>
<person name="Roylance R."/>
<person name="Sawyer E.J."/>
<person name="Kerr D.J."/>
<person name="Clark S."/>
<person name="Grimes J."/>
<person name="Kearsey S.E."/>
<person name="Thomas H.J."/>
<person name="McVean G."/>
<person name="Houlston R.S."/>
<person name="Tomlinson I."/>
</authorList>
<dbReference type="PubMed" id="23263490"/>
<dbReference type="DOI" id="10.1038/ng.2503"/>
</citation>
<scope>VARIANT CRC GLU-600</scope>
</reference>
<reference key="41">
<citation type="journal article" date="2014" name="Front. Oncol." volume="3" first="333" last="333">
<title>Evidence that GRIN2A mutations in melanoma correlate with decreased survival.</title>
<authorList>
<person name="D'mello S.A."/>
<person name="Flanagan J.U."/>
<person name="Green T.N."/>
<person name="Leung E.Y."/>
<person name="Askarian-Amiri M.E."/>
<person name="Joseph W.R."/>
<person name="McCrystal M.R."/>
<person name="Isaacs R.J."/>
<person name="Shaw J.H."/>
<person name="Furneaux C.E."/>
<person name="During M.J."/>
<person name="Finlay G.J."/>
<person name="Baguley B.C."/>
<person name="Kalev-Zylinska M.L."/>
</authorList>
<dbReference type="PubMed" id="24455489"/>
<dbReference type="DOI" id="10.3389/fonc.2013.00333"/>
</citation>
<scope>VARIANT CRC GLU-600</scope>
</reference>
<comment type="function">
<text evidence="39">Protein kinase involved in the transduction of mitogenic signals from the cell membrane to the nucleus. May play a role in the postsynaptic responses of hippocampal neuron. Phosphorylates MAP2K1, and thereby contributes to the MAP kinase signal transduction pathway.</text>
</comment>
<comment type="catalytic activity">
<text evidence="39">ATP + a protein = ADP + a phosphoprotein.</text>
</comment>
<comment type="cofactor">
<cofactor evidence="16">
<name>Zn(2+)</name>
<dbReference type="ChEBI" id="CHEBI:29105"/>
</cofactor>
<text evidence="16">Binds 2 Zn(2+) ions per subunit.</text>
</comment>
<comment type="enzyme regulation">
<text>Activity is increased by EGF and HGF.</text>
</comment>
<comment type="subunit">
<text evidence="16 34 37 38 39 40 45">Monomer. Homodimer. Heterodimerizes with RAF1, and the heterodimer possesses a highly increased kinase activity compared to the respective homodimers or monomers. Heterodimerization is mitogen-regulated and enhanced by 14-3-3 proteins. MAPK1/ERK2 activation can induce a negative feedback that promotes the dissociation of the heterodimer by phosphorylating BRAF at Thr-753. Found in a complex with at least BRAF, HRAS, MAP2K1, MAPK3 and RGS14. Interacts with RIT1. Interacts (via N-terminus) with RGS14 (via RBD domains); the interaction mediates the formation of a ternary complex with RAF1, a ternary complex inhibited by GNAI1 (By similarity). Interacts with DGKH (PubMed:19710016). Interacts with PRMT5 (PubMed:21917714). Interacts with KSR2 (PubMed:21441910). Interacts with AKAP13, MAP2K1 and KSR1. Identified in a complex with AKAP13, MAP2K1 and KSR1 (PubMed:21102438). Interacts with FNIP1 and FNIP2 (PubMed:27353360).</text>
</comment>
<comment type="interaction">
<interactant intactId="EBI-365980"/>
<interactant intactId="EBI-365980"/>
<organismsDiffer>false</organismsDiffer>
<experiments>9</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-365980"/>
<interactant intactId="EBI-365961">
<id>P10398</id>
<label>ARAF</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-365980"/>
<interactant intactId="EBI-352572">
<id>P08238</id>
<label>HSP90AB1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-365980"/>
<interactant intactId="EBI-1536336">
<id>Q61097</id>
<label>Ksr1</label>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-365980"/>
<interactant intactId="EBI-492564">
<id>Q02750</id>
<label>MAP2K1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>54</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-365980"/>
<interactant intactId="EBI-1056930">
<id>P36507</id>
<label>MAP2K2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>6</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-365980"/>
<interactant intactId="EBI-49776">
<id>Q13233</id>
<label>MAP3K1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-365980"/>
<interactant intactId="EBI-365996">
<id>P04049</id>
<label>RAF1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>46</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-365980"/>
<interactant intactId="EBI-397757">
<id>Q99N57</id>
<label>Raf1</label>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-365980"/>
<interactant intactId="EBI-7340552">
<id>Q8CGE9</id>
<label>Rgs12</label>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-365980"/>
<interactant intactId="EBI-1384149">
<id>Q15349</id>
<label>RPS6KA2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-365980"/>
<interactant intactId="EBI-357631">
<id>Q13114</id>
<label>TRAF3</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-365980"/>
<interactant intactId="EBI-359815">
<id>P31946</id>
<label>YWHAB</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-365980"/>
<interactant intactId="EBI-347088">
<id>P63104</id>
<label>YWHAZ</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location evidence="16">Nucleus</location>
</subcellularLocation>
<subcellularLocation>
<location>Cytoplasm</location>
</subcellularLocation>
<subcellularLocation>
<location evidence="16">Cell membrane</location>
</subcellularLocation>
<text evidence="16">Colocalizes with RGS14 and RAF1 in both the cytoplasm and membranes.</text>
</comment>
<comment type="tissue specificity">
<text>Brain and testis.</text>
</comment>
<comment type="PTM">
<text evidence="22 28 37 46">Phosphorylation at Ser-365 by SGK1 inhibits its activity.</text>
</comment>
<comment type="PTM">
<text evidence="40">Methylation at Arg-671 decreases stability and kinase activity.</text>
</comment>
<comment type="PTM">
<text evidence="41 43">Ubiquitinated by RNF149; which leads to proteasomal degradation. Polyubiquitinated at Lys-578 in response to EGF.</text>
</comment>
<comment type="disease">
<text evidence="35">Defects in BRAF are found in a wide range of cancers.</text>
</comment>
<comment type="disease" evidence="24 40 42 44">
<disease id="DI-01359">
<name>Colorectal cancer</name>
<acronym>CRC</acronym>
<description>A complex disease characterized by malignant lesions arising from the inner wall of the large intestine (the colon) and the rectum. Genetic alterations are often associated with progression from premalignant lesion (adenoma) to invasive adenocarcinoma. Risk factors for cancer of the colon and rectum include colon polyps, long-standing ulcerative colitis, and genetic family history.</description>
<dbReference type="MIM" id="114500"/>
</disease>
<text>The disease may be caused by mutations affecting the gene represented in this entry.</text>
</comment>
<comment type="disease" evidence="25">
<disease id="DI-02205">
<name>Lung cancer</name>
<acronym>LNCR</acronym>
<description>A common malignancy affecting tissues of the lung. The most common form of lung cancer is non-small cell lung cancer (NSCLC) that can be divided into 3 major histologic subtypes: squamous cell carcinoma, adenocarcinoma, and large cell lung cancer. NSCLC is often diagnosed at an advanced stage and has a poor prognosis.</description>
<dbReference type="MIM" id="211980"/>
</disease>
<text>The gene represented in this entry is involved in disease pathogenesis.</text>
</comment>
<comment type="disease" evidence="27">
<disease id="DI-01594">
<name>Familial non-Hodgkin lymphoma</name>
<acronym>NHL</acronym>
<description>Cancer that starts in cells of the lymph system, which is part of the body's immune system. NHLs can occur at any age and are often marked by enlarged lymph nodes, fever and weight loss.</description>
<dbReference type="MIM" id="605027"/>
</disease>
<text>The gene represented in this entry is involved in disease pathogenesis.</text>
</comment>
<comment type="disease" evidence="29 30 33 36">
<disease id="DI-01318">
<name>Cardiofaciocutaneous syndrome 1</name>
<acronym>CFC1</acronym>
<description>A multiple congenital anomaly disorder characterized by a distinctive facial appearance, heart defects and mental retardation. Heart defects include pulmonic stenosis, atrial septal defects and hypertrophic cardiomyopathy. Some affected individuals present with ectodermal abnormalities such as sparse, friable hair, hyperkeratotic skin lesions and a generalized ichthyosis-like condition. Typical facial features are similar to Noonan syndrome. They include high forehead with bitemporal constriction, hypoplastic supraorbital ridges, downslanting palpebral fissures, a depressed nasal bridge, and posteriorly angulated ears with prominent helices.</description>
<dbReference type="MIM" id="115150"/>
</disease>
<text>The disease is caused by mutations affecting the gene represented in this entry.</text>
</comment>
<comment type="disease" evidence="36">
<disease id="DI-02990">
<name>Noonan syndrome 7</name>
<acronym>NS7</acronym>
<description>A form of Noonan syndrome, a disease characterized by short stature, facial dysmorphic features such as hypertelorism, a downward eyeslant and low-set posteriorly rotated ears, and a high incidence of congenital heart defects and hypertrophic cardiomyopathy. Other features can include a short neck with webbing or redundancy of skin, deafness, motor delay, variable intellectual deficits, multiple skeletal defects, cryptorchidism, and bleeding diathesis. Individuals with Noonan syndrome are at risk of juvenile myelomonocytic leukemia, a myeloproliferative disorder characterized by excessive production of myelomonocytic cells.</description>
<dbReference type="MIM" id="613706"/>
</disease>
<text>The disease is caused by mutations affecting the gene represented in this entry.</text>
</comment>
<comment type="disease" evidence="36">
<disease id="DI-02991">
<name>LEOPARD syndrome 3</name>
<acronym>LPRD3</acronym>
<description>A disorder characterized by lentigines, electrocardiographic conduction abnormalities, ocular hypertelorism, pulmonic stenosis, abnormalities of genitalia, retardation of growth, and sensorineural deafness.</description>
<dbReference type="MIM" id="613707"/>
</disease>
<text>The disease is caused by mutations affecting the gene represented in this entry.</text>
</comment>
<comment type="disease">
<text evidence="35">A chromosomal aberration involving BRAF is found in pilocytic astrocytomas. A tandem duplication of 2 Mb at 7q34 leads to the expression of a KIAA1549-BRAF fusion protein with a constitutive kinase activity and inducing cell transformation.</text>
</comment>
<comment type="similarity">
<text evidence="47">Belongs to the protein kinase superfamily. TKL Ser/Thr protein kinase family. RAF subfamily.</text>
</comment>
<comment type="sequence caution" evidence="47">
<conflict type="erroneous gene model prediction">
<sequence resource="EMBL-CDS" id="AAD43193" version="1"/>
</conflict>
</comment>
<comment type="sequence caution" evidence="47">
<conflict type="erroneous initiation">
<sequence resource="EMBL-CDS" id="CAQ43111" version="1"/>
</conflict>
<text>Translation N-terminally shortened.</text>
</comment>
<comment type="sequence caution" evidence="47">
<conflict type="erroneous initiation">
<sequence resource="EMBL-CDS" id="CAQ43112" version="1"/>
</conflict>
<text>Translation N-terminally shortened.</text>
</comment>
<comment type="sequence caution" evidence="47">
<conflict type="erroneous initiation">
<sequence resource="EMBL-CDS" id="CAQ43113" version="1"/>
</conflict>
<text>Translation N-terminally shortened.</text>
</comment>
<comment type="sequence caution" evidence="47">
<conflict type="erroneous initiation">
<sequence resource="EMBL-CDS" id="CAQ43114" version="1"/>
</conflict>
<text>Translation N-terminally shortened.</text>
</comment>
<comment type="sequence caution" evidence="47">
<conflict type="erroneous initiation">
<sequence resource="EMBL-CDS" id="CAQ43115" version="1"/>
</conflict>
<text>Translation N-terminally shortened.</text>
</comment>
<comment type="sequence caution" evidence="47">
<conflict type="erroneous initiation">
<sequence resource="EMBL-CDS" id="CAQ43116" version="1"/>
</conflict>
<text>Translation N-terminally shortened.</text>
</comment>
<comment type="online information" name="Atlas of Genetics and Cytogenetics in Oncology and Haematology">
<link uri="http://atlasgeneticsoncology.org/Genes/BRAFID828.html"/>
</comment>
<dbReference type="EC" id="2.7.11.1"/>
<dbReference type="EMBL" id="M95712">
<property type="protein sequence ID" value="AAA35609.2"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AC006344">
<property type="protein sequence ID" value="AAD43193.1"/>
<property type="status" value="ALT_SEQ"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="EU600171">
<property type="protein sequence ID" value="ACD11489.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AC006347">
<property type="protein sequence ID" value="AAD15551.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="CH236950">
<property type="protein sequence ID" value="EAL24023.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="BC101757">
<property type="protein sequence ID" value="AAI01758.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BC112079">
<property type="protein sequence ID" value="AAI12080.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="X65187">
<property type="protein sequence ID" value="CAA46301.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="M21001">
<property type="protein sequence ID" value="AAA96495.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AM989472">
<property type="protein sequence ID" value="CAQ43111.1"/>
<property type="status" value="ALT_INIT"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AM989473">
<property type="protein sequence ID" value="CAQ43112.1"/>
<property type="status" value="ALT_INIT"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AM989474">
<property type="protein sequence ID" value="CAQ43113.1"/>
<property type="status" value="ALT_INIT"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AM989475">
<property type="protein sequence ID" value="CAQ43114.1"/>
<property type="status" value="ALT_INIT"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AM989476">
<property type="protein sequence ID" value="CAQ43115.1"/>
<property type="status" value="ALT_INIT"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AM989477">
<property type="protein sequence ID" value="CAQ43116.1"/>
<property type="status" value="ALT_INIT"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="CCDS" id="CCDS5863.1"/>
<dbReference type="PIR" id="A57977">
<property type="entry name" value="TVHUBF"/>
</dbReference>
<dbReference type="RefSeq" id="NP_004324.2">
<property type="nucleotide sequence ID" value="NM_004333.4"/>
</dbReference>
<dbReference type="UniGene" id="Hs.550061"/>
<dbReference type="UniGene" id="Hs.600998"/>
<dbReference type="UniGene" id="Hs.605380"/>
<dbReference type="UniGene" id="Hs.659507"/>
<dbReference type="UniGene" id="Hs.684552"/>
<dbReference type="PDB" id="1UWH">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.95"/>
<property type="chains" value="A/B=448-723"/>
</dbReference>
<dbReference type="PDB" id="1UWJ">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.50"/>
<property type="chains" value="A/B=448-723"/>
</dbReference>
<dbReference type="PDB" id="2FB8">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.90"/>
<property type="chains" value="A/B=445-723"/>
</dbReference>
<dbReference type="PDB" id="2L05">
<property type="method" value="NMR"/>
<property type="chains" value="A=149-232"/>
</dbReference>
<dbReference type="PDB" id="3C4C">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.57"/>
<property type="chains" value="A/B=444-721"/>
</dbReference>
<dbReference type="PDB" id="3D4Q">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.80"/>
<property type="chains" value="A/B=433-726"/>
</dbReference>
<dbReference type="PDB" id="3IDP">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.70"/>
<property type="chains" value="A/B=434-727"/>
</dbReference>
<dbReference type="PDB" id="3II5">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.79"/>
<property type="chains" value="A/B=432-726"/>
</dbReference>
<dbReference type="PDB" id="3NY5">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.99"/>
<property type="chains" value="A/B/C/D=153-237"/>
</dbReference>
<dbReference type="PDB" id="3OG7">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.45"/>
<property type="chains" value="A/B=448-720"/>
</dbReference>
<dbReference type="PDB" id="3PPJ">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.70"/>
<property type="chains" value="A/B=432-726"/>
</dbReference>
<dbReference type="PDB" id="3PPK">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.00"/>
<property type="chains" value="A/B=432-726"/>
</dbReference>
<dbReference type="PDB" id="3PRF">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.90"/>
<property type="chains" value="A/B=432-726"/>
</dbReference>
<dbReference type="PDB" id="3PRI">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.50"/>
<property type="chains" value="A/B=432-726"/>
</dbReference>
<dbReference type="PDB" id="3PSB">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.40"/>
<property type="chains" value="A/B=433-726"/>
</dbReference>
<dbReference type="PDB" id="3PSD">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.60"/>
<property type="chains" value="A/B=433-726"/>
</dbReference>
<dbReference type="PDB" id="3Q4C">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.20"/>
<property type="chains" value="A/B=432-726"/>
</dbReference>
<dbReference type="PDB" id="3Q96">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.10"/>
<property type="chains" value="A/B=446-727"/>
</dbReference>
<dbReference type="PDB" id="3SKC">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.20"/>
<property type="chains" value="A/B=432-726"/>
</dbReference>
<dbReference type="PDB" id="3TV4">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.40"/>
<property type="chains" value="A/B=432-726"/>
</dbReference>
<dbReference type="PDB" id="3TV6">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.30"/>
<property type="chains" value="A/B=432-726"/>
</dbReference>
<dbReference type="PDB" id="4CQE">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.30"/>
<property type="chains" value="A/B=448-723"/>
</dbReference>
<dbReference type="PDB" id="4DBN">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.15"/>
<property type="chains" value="A/B=445-726"/>
</dbReference>
<dbReference type="PDB" id="4E26">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.55"/>
<property type="chains" value="A/B=432-726"/>
</dbReference>
<dbReference type="PDB" id="4E4X">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.60"/>
<property type="chains" value="A/B=432-726"/>
</dbReference>
<dbReference type="PDB" id="4EHE">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.30"/>
<property type="chains" value="A/B=432-726"/>
</dbReference>
<dbReference type="PDB" id="4EHG">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.50"/>
<property type="chains" value="A/B=432-726"/>
</dbReference>
<dbReference type="PDB" id="4FC0">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.95"/>
<property type="chains" value="A/B=445-726"/>
</dbReference>
<dbReference type="PDB" id="4FK3">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.65"/>
<property type="chains" value="A/B=444-723"/>
</dbReference>
<dbReference type="PDB" id="4G9C">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.50"/>
<property type="chains" value="A/B=432-726"/>
</dbReference>
<dbReference type="PDB" id="4G9R">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.20"/>
<property type="chains" value="A/B=432-726"/>
</dbReference>
<dbReference type="PDB" id="4H58">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.10"/>
<property type="chains" value="A/B/C=448-722"/>
</dbReference>
<dbReference type="PDB" id="4JVG">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.09"/>
<property type="chains" value="A/B/C/D=444-723"/>
</dbReference>
<dbReference type="PDB" id="4KSP">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.93"/>
<property type="chains" value="A/B=445-726"/>
</dbReference>
<dbReference type="PDB" id="4KSQ">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.30"/>
<property type="chains" value="A/B=445-726"/>
</dbReference>
<dbReference type="PDB" id="4MBJ">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.60"/>
<property type="chains" value="A/B=432-723"/>
</dbReference>
<dbReference type="PDB" id="4MNE">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.85"/>
<property type="chains" value="B/C/F/G=432-726"/>
</dbReference>
<dbReference type="PDB" id="4MNF">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.80"/>
<property type="chains" value="A/B=432-736"/>
</dbReference>
<dbReference type="PDB" id="4PP7">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.40"/>
<property type="chains" value="A/B=432-726"/>
</dbReference>
<dbReference type="PDB" id="4R5Y">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.50"/>
<property type="chains" value="A/B=444-723"/>
</dbReference>
<dbReference type="PDB" id="4RZV">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.99"/>
<property type="chains" value="A/B=443-723"/>
</dbReference>
<dbReference type="PDB" id="4RZW">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.49"/>
<property type="chains" value="A/B=443-723"/>
</dbReference>
<dbReference type="PDB" id="4WO5">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.83"/>
<property type="chains" value="A/B=444-723"/>
</dbReference>
<dbReference type="PDB" id="4XV1">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.47"/>
<property type="chains" value="A/B=444-705"/>
</dbReference>
<dbReference type="PDB" id="4XV2">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.50"/>
<property type="chains" value="A/B=444-705"/>
</dbReference>
<dbReference type="PDB" id="4XV3">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.80"/>
<property type="chains" value="A/B=444-705"/>
</dbReference>
<dbReference type="PDB" id="4XV9">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.00"/>
<property type="chains" value="A=442-705"/>
</dbReference>
<dbReference type="PDB" id="4YHT">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.05"/>
<property type="chains" value="A/B=449-720"/>
</dbReference>
<dbReference type="PDB" id="5C9C">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.70"/>
<property type="chains" value="A/B=432-726"/>
</dbReference>
<dbReference type="PDB" id="5CSW">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.66"/>
<property type="chains" value="A/B=442-721"/>
</dbReference>
<dbReference type="PDB" id="5CSX">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.51"/>
<property type="chains" value="A=442-721"/>
</dbReference>
<dbReference type="PDB" id="5CT7">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.17"/>
<property type="chains" value="A/B=445-723"/>
</dbReference>
<dbReference type="PDB" id="5FD2">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.89"/>
<property type="chains" value="A/B=433-726"/>
</dbReference>
<dbReference type="PDB" id="5HI2">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.51"/>
<property type="chains" value="A=444-737"/>
</dbReference>
<dbReference type="PDB" id="5HID">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.50"/>
<property type="chains" value="A/B=444-737"/>
</dbReference>
<dbReference type="PDB" id="5HIE">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.00"/>
<property type="chains" value="A/B/C/D=432-726"/>
</dbReference>
<dbReference type="PDB" id="5ITA">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.95"/>
<property type="chains" value="A/B=448-723"/>
</dbReference>
<dbReference type="PDB" id="5J17">
<property type="method" value="NMR"/>
<property type="chains" value="A=151-232"/>
</dbReference>
<dbReference type="PDB" id="5J18">
<property type="method" value="NMR"/>
<property type="chains" value="A=151-232"/>
</dbReference>
<dbReference type="PDB" id="5J2R">
<property type="method" value="NMR"/>
<property type="chains" value="A=151-232"/>
</dbReference>
<dbReference type="PDB" id="5JRQ">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.29"/>
<property type="chains" value="A/B=448-723"/>
</dbReference>
<dbReference type="PDB" id="5JSM">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.19"/>
<property type="chains" value="A/B/C/D=448-723"/>
</dbReference>
<dbReference type="PDB" id="5JT2">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.70"/>
<property type="chains" value="A/B/C/D=448-723"/>
</dbReference>
<dbReference type="PDBsum" id="1UWH"/>
<dbReference type="PDBsum" id="1UWJ"/>
<dbReference type="PDBsum" id="2FB8"/>
<dbReference type="PDBsum" id="2L05"/>
<dbReference type="PDBsum" id="3C4C"/>
<dbReference type="PDBsum" id="3D4Q"/>
<dbReference type="PDBsum" id="3IDP"/>
<dbReference type="PDBsum" id="3II5"/>
<dbReference type="PDBsum" id="3NY5"/>
<dbReference type="PDBsum" id="3OG7"/>
<dbReference type="PDBsum" id="3PPJ"/>
<dbReference type="PDBsum" id="3PPK"/>
<dbReference type="PDBsum" id="3PRF"/>
<dbReference type="PDBsum" id="3PRI"/>
<dbReference type="PDBsum" id="3PSB"/>
<dbReference type="PDBsum" id="3PSD"/>
<dbReference type="PDBsum" id="3Q4C"/>
<dbReference type="PDBsum" id="3Q96"/>
<dbReference type="PDBsum" id="3SKC"/>
<dbReference type="PDBsum" id="3TV4"/>
<dbReference type="PDBsum" id="3TV6"/>
<dbReference type="PDBsum" id="4CQE"/>
<dbReference type="PDBsum" id="4DBN"/>
<dbReference type="PDBsum" id="4E26"/>
<dbReference type="PDBsum" id="4E4X"/>
<dbReference type="PDBsum" id="4EHE"/>
<dbReference type="PDBsum" id="4EHG"/>
<dbReference type="PDBsum" id="4FC0"/>
<dbReference type="PDBsum" id="4FK3"/>
<dbReference type="PDBsum" id="4G9C"/>
<dbReference type="PDBsum" id="4G9R"/>
<dbReference type="PDBsum" id="4H58"/>
<dbReference type="PDBsum" id="4JVG"/>
<dbReference type="PDBsum" id="4KSP"/>
<dbReference type="PDBsum" id="4KSQ"/>
<dbReference type="PDBsum" id="4MBJ"/>
<dbReference type="PDBsum" id="4MNE"/>
<dbReference type="PDBsum" id="4MNF"/>
<dbReference type="PDBsum" id="4PP7"/>
<dbReference type="PDBsum" id="4R5Y"/>
<dbReference type="PDBsum" id="4RZV"/>
<dbReference type="PDBsum" id="4RZW"/>
<dbReference type="PDBsum" id="4WO5"/>
<dbReference type="PDBsum" id="4XV1"/>
<dbReference type="PDBsum" id="4XV2"/>
<dbReference type="PDBsum" id="4XV3"/>
<dbReference type="PDBsum" id="4XV9"/>
<dbReference type="PDBsum" id="4YHT"/>
<dbReference type="PDBsum" id="5C9C"/>
<dbReference type="PDBsum" id="5CSW"/>
<dbReference type="PDBsum" id="5CSX"/>
<dbReference type="PDBsum" id="5CT7"/>
<dbReference type="PDBsum" id="5FD2"/>
<dbReference type="PDBsum" id="5HI2"/>
<dbReference type="PDBsum" id="5HID"/>
<dbReference type="PDBsum" id="5HIE"/>
<dbReference type="PDBsum" id="5ITA"/>
<dbReference type="PDBsum" id="5J17"/>
<dbReference type="PDBsum" id="5J18"/>
<dbReference type="PDBsum" id="5J2R"/>
<dbReference type="PDBsum" id="5JRQ"/>
<dbReference type="PDBsum" id="5JSM"/>
<dbReference type="PDBsum" id="5JT2"/>
<dbReference type="ProteinModelPortal" id="P15056"/>
<dbReference type="SMR" id="P15056"/>
<dbReference type="BioGrid" id="107141">
<property type="interactions" value="51"/>
</dbReference>
<dbReference type="DIP" id="DIP-1045N"/>
<dbReference type="IntAct" id="P15056">
<property type="interactions" value="45"/>
</dbReference>
<dbReference type="MINT" id="MINT-1574728"/>
<dbReference type="STRING" id="9606.ENSP00000288602"/>
<dbReference type="BindingDB" id="P15056"/>
<dbReference type="ChEMBL" id="CHEMBL5145"/>
<dbReference type="DrugBank" id="DB08912">
<property type="generic name" value="Dabrafenib"/>
</dbReference>
<dbReference type="DrugBank" id="DB05238">
<property type="generic name" value="PLX4032"/>
</dbReference>
<dbReference type="DrugBank" id="DB08896">
<property type="generic name" value="Regorafenib"/>
</dbReference>
<dbReference type="DrugBank" id="DB00398">
<property type="generic name" value="Sorafenib"/>
</dbReference>
<dbReference type="DrugBank" id="DB08881">
<property type="generic name" value="Vemurafenib"/>
</dbReference>
<dbReference type="DrugBank" id="DB05190">
<property type="generic name" value="XL281"/>
</dbReference>
<dbReference type="GuidetoPHARMACOLOGY" id="1943"/>
<dbReference type="iPTMnet" id="P15056"/>
<dbReference type="PhosphoSitePlus" id="P15056"/>
<dbReference type="BioMuta" id="BRAF"/>
<dbReference type="DMDM" id="50403720"/>
<dbReference type="EPD" id="P15056"/>
<dbReference type="MaxQB" id="P15056"/>
<dbReference type="PaxDb" id="P15056"/>
<dbReference type="PeptideAtlas" id="P15056"/>
<dbReference type="PRIDE" id="P15056"/>
<dbReference type="DNASU" id="673"/>
<dbReference type="Ensembl" id="ENST00000288602">
<property type="protein sequence ID" value="ENSP00000288602"/>
<property type="gene ID" value="ENSG00000157764"/>
</dbReference>
<dbReference type="GeneID" id="673"/>
<dbReference type="KEGG" id="hsa:673"/>
<dbReference type="UCSC" id="uc003vwc.5">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="CTD" id="673"/>
<dbReference type="DisGeNET" id="673"/>
<dbReference type="GeneCards" id="BRAF"/>
<dbReference type="GeneReviews" id="BRAF"/>
<dbReference type="H-InvDB" id="HIX0167822"/>
<dbReference type="HGNC" id="HGNC:1097">
<property type="gene designation" value="BRAF"/>
</dbReference>
<dbReference type="HPA" id="CAB004552"/>
<dbReference type="HPA" id="HPA001328"/>
<dbReference type="HPA" id="HPA071048"/>
<dbReference type="MalaCards" id="BRAF"/>
<dbReference type="MIM" id="114500">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="MIM" id="115150">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="MIM" id="164757">
<property type="type" value="gene"/>
</dbReference>
<dbReference type="MIM" id="211980">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="MIM" id="605027">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="MIM" id="613706">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="MIM" id="613707">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="neXtProt" id="NX_P15056"/>
<dbReference type="OpenTargets" id="ENSG00000157764"/>
<dbReference type="Orphanet" id="1340">
<property type="disease" value="Cardiofaciocutaneous syndrome"/>
</dbReference>
<dbReference type="Orphanet" id="54595">
<property type="disease" value="Craniopharyngioma"/>
</dbReference>
<dbReference type="Orphanet" id="58017">
<property type="disease" value="Hairy cell leukemia"/>
</dbReference>
<dbReference type="Orphanet" id="99872">
<property type="disease" value="Hashimoto-Pritzker syndrome"/>
</dbReference>
<dbReference type="Orphanet" id="500">
<property type="disease" value="LEOPARD syndrome"/>
</dbReference>
<dbReference type="Orphanet" id="648">
<property type="disease" value="Noonan syndrome"/>
</dbReference>
<dbReference type="Orphanet" id="251612">
<property type="disease" value="Pilocytic astrocytoma"/>
</dbReference>
<dbReference type="PharmGKB" id="PA25408"/>
<dbReference type="eggNOG" id="KOG0193">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="eggNOG" id="ENOG410Y4UP">
<property type="taxonomic scope" value="LUCA"/>
</dbReference>
<dbReference type="GeneTree" id="ENSGT00760000118807"/>
<dbReference type="HOVERGEN" id="HBG001886"/>
<dbReference type="InParanoid" id="P15056"/>
<dbReference type="KO" id="K04365"/>
<dbReference type="OMA" id="CQQRERK"/>
<dbReference type="OrthoDB" id="EOG091G09SB"/>
<dbReference type="PhylomeDB" id="P15056"/>
<dbReference type="TreeFam" id="TF317006"/>
<dbReference type="BRENDA" id="2.7.10.2">
<property type="organism ID" value="2681"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-1295596">
<property type="pathway name" value="Spry regulation of FGF signaling"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-170968">
<property type="pathway name" value="Frs2-mediated activation"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-170984">
<property type="pathway name" value="ARMS-mediated activation"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-187706">
<property type="pathway name" value="Signalling to p38 via RIT and RIN"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-442742">
<property type="pathway name" value="CREB phosphorylation through the activation of Ras"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5673000">
<property type="pathway name" value="RAF activation"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5674135">
<property type="pathway name" value="MAP2K and MAPK activation"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5674499">
<property type="pathway name" value="Negative feedback regulation of MAPK pathway"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5675221">
<property type="pathway name" value="Negative regulation of MAPK pathway"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-6802946">
<property type="pathway name" value="Signaling by moderate kinase activity BRAF mutants"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-6802948">
<property type="pathway name" value="Signaling by high-kinase activity BRAF mutants"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-6802949">
<property type="pathway name" value="Signaling by RAS mutants"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-6802952">
<property type="pathway name" value="Signaling by BRAF and RAF fusions"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-6802955">
<property type="pathway name" value="Paradoxical activation of RAF signaling by kinase inactive BRAF"/>
</dbReference>
<dbReference type="SignaLink" id="P15056"/>
<dbReference type="SIGNOR" id="P15056"/>
<dbReference type="ChiTaRS" id="BRAF">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="EvolutionaryTrace" id="P15056"/>
<dbReference type="GeneWiki" id="BRAF_(gene)"/>
<dbReference type="GenomeRNAi" id="673"/>
<dbReference type="PMAP-CutDB" id="P15056"/>
<dbReference type="PRO" id="PR:P15056"/>
<dbReference type="Proteomes" id="UP000005640">
<property type="component" value="Chromosome 7"/>
</dbReference>
<dbReference type="Bgee" id="ENSG00000157764"/>
<dbReference type="CleanEx" id="HS_BRAF"/>
<dbReference type="ExpressionAtlas" id="P15056">
<property type="expression patterns" value="baseline and differential"/>
</dbReference>
<dbReference type="Genevisible" id="P15056">
<property type="organism ID" value="HS"/>
</dbReference>
<dbReference type="GO" id="GO:0044297">
<property type="term" value="C:cell body"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0005829">
<property type="term" value="C:cytosol"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="HPA"/>
</dbReference>
<dbReference type="GO" id="GO:0005622">
<property type="term" value="C:intracellular"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0043231">
<property type="term" value="C:intracellular membrane-bounded organelle"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="HPA"/>
</dbReference>
<dbReference type="GO" id="GO:0005739">
<property type="term" value="C:mitochondrion"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0043005">
<property type="term" value="C:neuron projection"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0005634">
<property type="term" value="C:nucleus"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-SubCell"/>
</dbReference>
<dbReference type="GO" id="GO:0005886">
<property type="term" value="C:plasma membrane"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0005524">
<property type="term" value="F:ATP binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0005509">
<property type="term" value="F:calcium ion binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0042802">
<property type="term" value="F:identical protein binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="IntAct"/>
</dbReference>
<dbReference type="GO" id="GO:0004709">
<property type="term" value="F:MAP kinase kinase kinase activity"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0031434">
<property type="term" value="F:mitogen-activated protein kinase kinase binding"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0046982">
<property type="term" value="F:protein heterodimerization activity"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0004672">
<property type="term" value="F:protein kinase activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0004674">
<property type="term" value="F:protein serine/threonine kinase activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0009887">
<property type="term" value="P:animal organ morphogenesis"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0043369">
<property type="term" value="P:CD4-positive or CD8-positive, alpha-beta T cell lineage commitment"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0043367">
<property type="term" value="P:CD4-positive, alpha-beta T cell differentiation"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0030154">
<property type="term" value="P:cell differentiation"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0071277">
<property type="term" value="P:cellular response to calcium ion"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0035690">
<property type="term" value="P:cellular response to drug"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:1990090">
<property type="term" value="P:cellular response to nerve growth factor stimulus"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0090150">
<property type="term" value="P:establishment of protein localization to membrane"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="CACAO"/>
</dbReference>
<dbReference type="GO" id="GO:0060324">
<property type="term" value="P:face development"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0015758">
<property type="term" value="P:glucose transport"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="CACAO"/>
</dbReference>
<dbReference type="GO" id="GO:0060323">
<property type="term" value="P:head morphogenesis"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0060291">
<property type="term" value="P:long-term synaptic potentiation"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0000165">
<property type="term" value="P:MAPK cascade"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0002318">
<property type="term" value="P:myeloid progenitor cell differentiation"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0043066">
<property type="term" value="P:negative regulation of apoptotic process"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:2000352">
<property type="term" value="P:negative regulation of endothelial cell apoptotic process"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0010764">
<property type="term" value="P:negative regulation of fibroblast migration"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0043524">
<property type="term" value="P:negative regulation of neuron apoptotic process"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0009968">
<property type="term" value="P:negative regulation of signal transduction"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:2000301">
<property type="term" value="P:negative regulation of synaptic vesicle exocytosis"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0048680">
<property type="term" value="P:positive regulation of axon regeneration"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0050772">
<property type="term" value="P:positive regulation of axonogenesis"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0070374">
<property type="term" value="P:positive regulation of ERK1 and ERK2 cascade"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0010628">
<property type="term" value="P:positive regulation of gene expression"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0033138">
<property type="term" value="P:positive regulation of peptidyl-serine phosphorylation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0051496">
<property type="term" value="P:positive regulation of stress fiber assembly"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:1900026">
<property type="term" value="P:positive regulation of substrate adhesion-dependent cell spreading"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0051291">
<property type="term" value="P:protein heterooligomerization"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0006468">
<property type="term" value="P:protein phosphorylation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0042127">
<property type="term" value="P:regulation of cell proliferation"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0045580">
<property type="term" value="P:regulation of T cell differentiation"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0051591">
<property type="term" value="P:response to cAMP"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0043434">
<property type="term" value="P:response to peptide hormone"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0035019">
<property type="term" value="P:somatic stem cell population maintenance"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0050852">
<property type="term" value="P:T cell receptor signaling pathway"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0048538">
<property type="term" value="P:thymus development"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0030878">
<property type="term" value="P:thyroid gland development"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0008542">
<property type="term" value="P:visual learning"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="CDD" id="cd00029">
<property type="entry name" value="C1"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="InterPro" id="IPR020454">
<property type="entry name" value="DAG/PE-bd"/>
</dbReference>
<dbReference type="InterPro" id="IPR011009">
<property type="entry name" value="Kinase-like_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR002219">
<property type="entry name" value="PE/DAG-bd"/>
</dbReference>
<dbReference type="InterPro" id="IPR000719">
<property type="entry name" value="Prot_kinase_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR017441">
<property type="entry name" value="Protein_kinase_ATP_BS"/>
</dbReference>
<dbReference type="InterPro" id="IPR003116">
<property type="entry name" value="RBD_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR001245">
<property type="entry name" value="Ser-Thr/Tyr_kinase_cat_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR008271">
<property type="entry name" value="Ser/Thr_kinase_AS"/>
</dbReference>
<dbReference type="InterPro" id="IPR029071">
<property type="entry name" value="Ubiquitin-rel_dom"/>
</dbReference>
<dbReference type="Pfam" id="PF00130">
<property type="entry name" value="C1_1"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF07714">
<property type="entry name" value="Pkinase_Tyr"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF02196">
<property type="entry name" value="RBD"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PRINTS" id="PR00008">
<property type="entry name" value="DAGPEDOMAIN"/>
</dbReference>
<dbReference type="SMART" id="SM00109">
<property type="entry name" value="C1"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SMART" id="SM00455">
<property type="entry name" value="RBD"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SMART" id="SM00220">
<property type="entry name" value="S_TKc"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF54236">
<property type="entry name" value="SSF54236"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF56112">
<property type="entry name" value="SSF56112"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS00107">
<property type="entry name" value="PROTEIN_KINASE_ATP"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS50011">
<property type="entry name" value="PROTEIN_KINASE_DOM"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS00108">
<property type="entry name" value="PROTEIN_KINASE_ST"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS50898">
<property type="entry name" value="RBD"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS00479">
<property type="entry name" value="ZF_DAG_PE_1"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS50081">
<property type="entry name" value="ZF_DAG_PE_2"/>
<property type="match status" value="1"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0002">3D-structure</keyword>
<keyword id="KW-0007">Acetylation</keyword>
<keyword id="KW-0067">ATP-binding</keyword>
<keyword id="KW-0122">Cardiomyopathy</keyword>
<keyword id="KW-1003">Cell membrane</keyword>
<keyword id="KW-0160">Chromosomal rearrangement</keyword>
<keyword id="KW-0181">Complete proteome</keyword>
<keyword id="KW-0963">Cytoplasm</keyword>
<keyword id="KW-0209">Deafness</keyword>
<keyword id="KW-0903">Direct protein sequencing</keyword>
<keyword id="KW-0225">Disease mutation</keyword>
<keyword id="KW-0038">Ectodermal dysplasia</keyword>
<keyword id="KW-1017">Isopeptide bond</keyword>
<keyword id="KW-0418">Kinase</keyword>
<keyword id="KW-0472">Membrane</keyword>
<keyword id="KW-0991">Mental retardation</keyword>
<keyword id="KW-0479">Metal-binding</keyword>
<keyword id="KW-0488">Methylation</keyword>
<keyword id="KW-0547">Nucleotide-binding</keyword>
<keyword id="KW-0539">Nucleus</keyword>
<keyword id="KW-0597">Phosphoprotein</keyword>
<keyword id="KW-0621">Polymorphism</keyword>
<keyword id="KW-0656">Proto-oncogene</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0723">Serine/threonine-protein kinase</keyword>
<keyword id="KW-0808">Transferase</keyword>
<keyword id="KW-0832">Ubl conjugation</keyword>
<keyword id="KW-0862">Zinc</keyword>
<keyword id="KW-0863">Zinc-finger</keyword>
<feature type="initiator methionine" description="Removed" evidence="46">
<location>
<position position="1"/>
</location>
</feature>
<feature type="chain" description="Serine/threonine-protein kinase B-raf" id="PRO_0000085665">
<location>
<begin position="2"/>
<end position="766"/>
</location>
</feature>
<feature type="domain" description="RBD" evidence="20">
<location>
<begin position="155"/>
<end position="227"/>
</location>
</feature>
<feature type="domain" description="Protein kinase" evidence="18">
<location>
<begin position="457"/>
<end position="717"/>
</location>
</feature>
<feature type="zinc finger region" description="Phorbol-ester/DAG-type" evidence="19">
<location>
<begin position="234"/>
<end position="280"/>
</location>
</feature>
<feature type="nucleotide phosphate-binding region" description="ATP" evidence="18">
<location>
<begin position="463"/>
<end position="471"/>
</location>
</feature>
<feature type="compositionally biased region" description="Poly-Gly">
<location>
<begin position="6"/>
<end position="11"/>
</location>
</feature>
<feature type="compositionally biased region" description="Poly-Ser">
<location>
<begin position="122"/>
<end position="129"/>
</location>
</feature>
<feature type="compositionally biased region" description="Poly-Ser">
<location>
<begin position="428"/>
<end position="432"/>
</location>
</feature>
<feature type="active site" description="Proton acceptor" evidence="18 21">
<location>
<position position="576"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Zinc 1" evidence="16">
<location>
<position position="235"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Zinc 2" evidence="16">
<location>
<position position="248"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Zinc 2" evidence="16">
<location>
<position position="251"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Zinc 1" evidence="16">
<location>
<position position="261"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Zinc 1" evidence="16">
<location>
<position position="264"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Zinc 2" evidence="16">
<location>
<position position="269"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Zinc 2" evidence="16">
<location>
<position position="272"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Zinc 1" evidence="16">
<location>
<position position="280"/>
</location>
</feature>
<feature type="binding site" description="ATP" evidence="18">
<location>
<position position="483"/>
</location>
</feature>
<feature type="site" description="Breakpoint for translocation to form KIAA1549-BRAF fusion protein">
<location>
<begin position="380"/>
<end position="381"/>
</location>
</feature>
<feature type="site" description="Breakpoint for translocation to form KIAA1549-BRAF fusion protein">
<location>
<begin position="438"/>
<end position="439"/>
</location>
</feature>
<feature type="modified residue" description="N-acetylalanine" evidence="46">
<location>
<position position="2"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="14 15">
<location>
<position position="151"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="17">
<location>
<position position="333"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; by SGK1" evidence="14 22 46">
<location>
<position position="365"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine; by autocatalysis" evidence="28">
<location>
<position position="373"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine" evidence="46">
<location>
<position position="396"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="46">
<location>
<position position="399"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine" evidence="11 12 14 46">
<location>
<position position="401"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="12 14">
<location>
<position position="446"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="12">
<location>
<position position="447"/>
</location>
</feature>
<feature type="modified residue" description="Omega-N-methylarginine; by PRMT5" evidence="40">
<location>
<position position="671"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="12 13 14 46">
<location>
<position position="729"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="17">
<location>
<position position="750"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine; by MAPK1" evidence="37">
<location>
<position position="753"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin)" evidence="43">
<location>
<position position="578"/>
</location>
</feature>
<feature type="sequence variant" description="In a patient with Noonan syndrome; dbSNP:rs387906660." id="VAR_058620" evidence="36">
<original>T</original>
<variation>M</variation>
<location>
<position position="241"/>
</location>
</feature>
<feature type="sequence variant" description="In CFC1 and LPRD3; dbSNP:rs387906661." id="VAR_058621" evidence="33 36">
<original>T</original>
<variation>P</variation>
<location>
<position position="241"/>
</location>
</feature>
<feature type="sequence variant" description="In a patient with Noonan syndrome; dbSNP:rs387906660." id="VAR_058622" evidence="36">
<original>T</original>
<variation>R</variation>
<location>
<position position="241"/>
</location>
</feature>
<feature type="sequence variant" description="In CFC1; dbSNP:rs397507465." id="VAR_065171" evidence="33">
<original>T</original>
<variation>P</variation>
<location>
<position position="244"/>
</location>
</feature>
<feature type="sequence variant" description="In CFC1; dbSNP:rs397507466." id="VAR_058623" evidence="36">
<original>L</original>
<variation>F</variation>
<location>
<position position="245"/>
</location>
</feature>
<feature type="sequence variant" description="In CFC1; dbSNP:rs180177034." id="VAR_026113" evidence="30 33 36">
<original>A</original>
<variation>P</variation>
<location>
<position position="246"/>
</location>
</feature>
<feature type="sequence variant" description="In CFC1; dbSNP:rs180177035." id="VAR_026114" evidence="29 30 33 36">
<original>Q</original>
<variation>R</variation>
<location>
<position position="257"/>
</location>
</feature>
<feature type="sequence variant" description="In CFC1; dbSNP:rs397507470." id="VAR_065172" evidence="33">
<original>Q</original>
<variation>K</variation>
<location>
<position position="262"/>
</location>
</feature>
<feature type="sequence variant" description="In CFC1." id="VAR_058624" evidence="36">
<original>E</original>
<variation>K</variation>
<location>
<position position="275"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs34776339." id="VAR_040391" evidence="32">
<original>P</original>
<variation>S</variation>
<location>
<position position="301"/>
</location>
</feature>
<feature type="sequence variant" description="In CRC; dbSNP:rs180177032." id="VAR_018613" evidence="24">
<original>R</original>
<variation>I</variation>
<location>
<position position="462"/>
</location>
</feature>
<feature type="sequence variant" description="In CRC; dbSNP:rs180177033." id="VAR_018614" evidence="24">
<original>I</original>
<variation>S</variation>
<location>
<position position="463"/>
</location>
</feature>
<feature type="sequence variant" description="In CRC; dbSNP:rs121913348." id="VAR_018615" evidence="23 24">
<original>G</original>
<variation>E</variation>
<location>
<position position="464"/>
</location>
</feature>
<feature type="sequence variant" description="In a colorectal cancer cell line; elevated kinase activity; efficiently induces cell transformation; dbSNP:rs121913348." id="VAR_018616" evidence="23">
<original>G</original>
<variation>V</variation>
<location>
<position position="464"/>
</location>
</feature>
<feature type="sequence variant" description="In melanoma; dbSNP:rs121913351." id="VAR_018617" evidence="23">
<original>G</original>
<variation>A</variation>
<location>
<position position="466"/>
</location>
</feature>
<feature type="sequence variant" description="In melanoma; dbSNP:rs121913351." id="VAR_018618" evidence="23">
<original>G</original>
<variation>E</variation>
<location>
<position position="466"/>
</location>
</feature>
<feature type="sequence variant" description="In LNCR; dbSNP:rs121913351." id="VAR_018512" evidence="23 25">
<original>G</original>
<variation>V</variation>
<location>
<position position="466"/>
</location>
</feature>
<feature type="sequence variant" description="In CFC1; dbSNP:rs869025606." id="VAR_035096" evidence="29">
<original>S</original>
<variation>A</variation>
<location>
<position position="467"/>
</location>
</feature>
<feature type="sequence variant" description="In CFC1; dbSNP:rs397507473." id="VAR_035097" evidence="29 33">
<original>F</original>
<variation>S</variation>
<location>
<position position="468"/>
</location>
</feature>
<feature type="sequence variant" description="In NHL; also in a lung adenocarcinoma sample; somatic mutation; elevated kinase activity; efficiently induces cell transformation; dbSNP:rs121913355." id="VAR_018620" evidence="23 27 32">
<original>G</original>
<variation>A</variation>
<location>
<position position="469"/>
</location>
</feature>
<feature type="sequence variant" description="In CFC1 and colon cancer; dbSNP:rs121913355." id="VAR_018621" evidence="23 29 30 33 36">
<original>G</original>
<variation>E</variation>
<location>
<position position="469"/>
</location>
</feature>
<feature type="sequence variant" description="In NHL; dbSNP:rs121913357." id="VAR_018622" evidence="27">
<original>G</original>
<variation>R</variation>
<location>
<position position="469"/>
</location>
</feature>
<feature type="sequence variant" description="In a colorectal adenocarcinoma sample; somatic mutation; dbSNP:rs121913355." id="VAR_040392" evidence="32">
<original>G</original>
<variation>V</variation>
<location>
<position position="469"/>
</location>
</feature>
<feature type="sequence variant" description="In CFC1; dbSNP:rs180177036." id="VAR_026115" evidence="29 30 36">
<original>L</original>
<variation>F</variation>
<location>
<position position="485"/>
</location>
</feature>
<feature type="sequence variant" description="In CFC1; dbSNP:rs180177037." id="VAR_026116" evidence="29 30 33">
<original>K</original>
<variation>E</variation>
<location>
<position position="499"/>
</location>
</feature>
<feature type="sequence variant" description="In CFC1; dbSNP:rs397507476." id="VAR_058625" evidence="33 36">
<original>K</original>
<variation>N</variation>
<location>
<position position="499"/>
</location>
</feature>
<feature type="sequence variant" description="In CFC1; dbSNP:rs180177039." id="VAR_026117" evidence="29 30">
<original>E</original>
<variation>G</variation>
<location>
<position position="501"/>
</location>
</feature>
<feature type="sequence variant" description="In CFC1; dbSNP:rs180177038." id="VAR_026118" evidence="29 30 36">
<original>E</original>
<variation>K</variation>
<location>
<position position="501"/>
</location>
</feature>
<feature type="sequence variant" description="In CFC1; dbSNP:rs869025340." id="VAR_058626" evidence="36">
<original>L</original>
<variation>P</variation>
<location>
<position position="525"/>
</location>
</feature>
<feature type="sequence variant" description="In NS7; dbSNP:rs606231228." id="VAR_058627" evidence="36">
<original>W</original>
<variation>C</variation>
<location>
<position position="531"/>
</location>
</feature>
<feature type="sequence variant" description="In CFC1." id="VAR_065173" evidence="33">
<original>N</original>
<variation>D</variation>
<location>
<position position="580"/>
</location>
</feature>
<feature type="sequence variant" description="In CFC1; dbSNP:rs180177040." id="VAR_026119" evidence="29 30 33">
<original>N</original>
<variation>D</variation>
<location>
<position position="581"/>
</location>
</feature>
<feature type="sequence variant" description="In a colorectal adenocarcinoma sample; somatic mutation; dbSNP:rs121913370." id="VAR_040393" evidence="32">
<original>N</original>
<variation>S</variation>
<location>
<position position="581"/>
</location>
</feature>
<feature type="sequence variant" description="In ovarian cancer; dbSNP:rs121913340." id="VAR_018623" evidence="23">
<original>E</original>
<variation>K</variation>
<location>
<position position="586"/>
</location>
</feature>
<feature type="sequence variant" description="In NHL; dbSNP:rs121913338." id="VAR_018624" evidence="27">
<original>D</original>
<variation>G</variation>
<location>
<position position="594"/>
</location>
</feature>
<feature type="sequence variant" description="In colon cancer and CFC1; dbSNP:rs121913341." id="VAR_018625" evidence="23 29 33 36">
<original>F</original>
<variation>L</variation>
<location>
<position position="595"/>
</location>
</feature>
<feature type="sequence variant" description="In a colorectal adenocarcinoma sample; somatic mutation; dbSNP:rs121913361." id="VAR_018626" evidence="23 32">
<original>G</original>
<variation>R</variation>
<location>
<position position="596"/>
</location>
</feature>
<feature type="sequence variant" description="In CFC1; dbSNP:rs397507483." id="VAR_035098" evidence="29">
<original>G</original>
<variation>V</variation>
<location>
<position position="596"/>
</location>
</feature>
<feature type="sequence variant" description="In LNCR; also found in an ovarian serous carcinoma sample; somatic mutation; dbSNP:rs121913366." id="VAR_018513" evidence="23 25 32">
<original>L</original>
<variation>R</variation>
<location>
<position position="597"/>
</location>
</feature>
<feature type="sequence variant" description="In NS7; also in a lung adenocarcinoma sample; somatic mutation; elevated kinase activity; efficiently induces cell transformation; dbSNP:rs121913369." id="VAR_018627" evidence="23 32 36">
<original>L</original>
<variation>V</variation>
<location>
<position position="597"/>
</location>
</feature>
<feature type="sequence variant" description="In CFC1." id="VAR_058628" evidence="36">
<original>T</original>
<variation>R</variation>
<location>
<position position="599"/>
</location>
</feature>
<feature type="sequence variant" description="In a melanoma cell line; requires 2 nucleotide substitutions; dbSNP:rs121913377." id="VAR_018628" evidence="23">
<original>V</original>
<variation>D</variation>
<location>
<position position="600"/>
</location>
</feature>
<feature type="sequence variant" description="In CRC; also found in sarcoma, metastatic melanoma, ovarian serous carcinoma, pilocytic astrocytoma; somatic mutation; most common mutation; constitutive and elevated kinase activity; efficiently induces cell transformation; suppression of mutation in melanoma causes growth arrest and promotes apoptosis; loss of regulation by PMRT5; dbSNP:rs113488022." id="VAR_018629" evidence="23 24 26 31 32 40 42 44">
<original>V</original>
<variation>E</variation>
<location>
<position position="600"/>
</location>
</feature>
<feature type="sequence variant" description="In CRC; dbSNP:rs121913364." id="VAR_018630" evidence="24">
<original>K</original>
<variation>E</variation>
<location>
<position position="601"/>
</location>
</feature>
<feature type="sequence variant" description="In CFC1; dbSNP:rs121913364." id="VAR_058629" evidence="36">
<original>K</original>
<variation>Q</variation>
<location>
<position position="601"/>
</location>
</feature>
<feature type="sequence variant" description="In CFC1; dbSNP:rs180177042." id="VAR_058630" evidence="36">
<original>D</original>
<variation>E</variation>
<location>
<position position="638"/>
</location>
</feature>
<feature type="sequence variant" description="In CFC1; dbSNP:rs397507486." id="VAR_058631" evidence="36">
<original>Q</original>
<variation>R</variation>
<location>
<position position="709"/>
</location>
</feature>
<feature type="mutagenesis site" description="Reduces kinase activity with MAP2K1." evidence="39">
<original>K</original>
<variation>S</variation>
<location>
<position position="483"/>
</location>
</feature>
<feature type="mutagenesis site" description="Blocks EGF-induced ubiquitination and ERK activation." evidence="43">
<original>K</original>
<variation>R</variation>
<location>
<position position="578"/>
</location>
</feature>
<feature type="mutagenesis site" description="Increased kinase activity and stability in response to EGF treatment." evidence="40">
<original>R</original>
<variation>K</variation>
<location>
<position position="671"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 11; AAA96495." ref="11" evidence="47">
<original>H</original>
<variation>D</variation>
<location>
<position position="766"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="156"/>
<end position="161"/>
</location>
</feature>
<feature type="turn" evidence="1">
<location>
<begin position="162"/>
<end position="164"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="165"/>
<end position="170"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="177"/>
<end position="186"/>
</location>
</feature>
<feature type="turn" evidence="1">
<location>
<begin position="187"/>
<end position="189"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="192"/>
<end position="194"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="195"/>
<end position="199"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="206"/>
<end position="208"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="214"/>
<end position="217"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="221"/>
<end position="226"/>
</location>
</feature>
<feature type="helix" evidence="9">
<location>
<begin position="448"/>
<end position="450"/>
</location>
</feature>
<feature type="helix" evidence="9">
<location>
<begin position="454"/>
<end position="456"/>
</location>
</feature>
<feature type="strand" evidence="8">
<location>
<begin position="458"/>
<end position="466"/>
</location>
</feature>
<feature type="strand" evidence="8">
<location>
<begin position="469"/>
<end position="486"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="487"/>
<end position="489"/>
</location>
</feature>
<feature type="helix" evidence="8">
<location>
<begin position="492"/>
<end position="506"/>
</location>
</feature>
<feature type="strand" evidence="8">
<location>
<begin position="516"/>
<end position="520"/>
</location>
</feature>
<feature type="strand" evidence="8">
<location>
<begin position="522"/>
<end position="524"/>
</location>
</feature>
<feature type="strand" evidence="8">
<location>
<begin position="526"/>
<end position="530"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="534"/>
<end position="536"/>
</location>
</feature>
<feature type="helix" evidence="8">
<location>
<begin position="537"/>
<end position="542"/>
</location>
</feature>
<feature type="strand" evidence="5">
<location>
<begin position="543"/>
<end position="545"/>
</location>
</feature>
<feature type="helix" evidence="8">
<location>
<begin position="550"/>
<end position="569"/>
</location>
</feature>
<feature type="helix" evidence="8">
<location>
<begin position="579"/>
<end position="581"/>
</location>
</feature>
<feature type="strand" evidence="8">
<location>
<begin position="582"/>
<end position="585"/>
</location>
</feature>
<feature type="turn" evidence="8">
<location>
<begin position="586"/>
<end position="588"/>
</location>
</feature>
<feature type="strand" evidence="8">
<location>
<begin position="589"/>
<end position="592"/>
</location>
</feature>
<feature type="turn" evidence="10">
<location>
<begin position="598"/>
<end position="600"/>
</location>
</feature>
<feature type="turn" evidence="4">
<location>
<begin position="602"/>
<end position="605"/>
</location>
</feature>
<feature type="helix" evidence="6">
<location>
<begin position="611"/>
<end position="613"/>
</location>
</feature>
<feature type="turn" evidence="7">
<location>
<begin position="614"/>
<end position="616"/>
</location>
</feature>
<feature type="helix" evidence="8">
<location>
<begin position="617"/>
<end position="619"/>
</location>
</feature>
<feature type="helix" evidence="8">
<location>
<begin position="622"/>
<end position="625"/>
</location>
</feature>
<feature type="turn" evidence="7">
<location>
<begin position="626"/>
<end position="629"/>
</location>
</feature>
<feature type="helix" evidence="8">
<location>
<begin position="635"/>
<end position="651"/>
</location>
</feature>
<feature type="turn" evidence="8">
<location>
<begin position="655"/>
<end position="659"/>
</location>
</feature>
<feature type="helix" evidence="8">
<location>
<begin position="662"/>
<end position="670"/>
</location>
</feature>
<feature type="helix" evidence="8">
<location>
<begin position="678"/>
<end position="680"/>
</location>
</feature>
<feature type="strand" evidence="9">
<location>
<begin position="683"/>
<end position="685"/>
</location>
</feature>
<feature type="helix" evidence="8">
<location>
<begin position="687"/>
<end position="696"/>
</location>
</feature>
<feature type="helix" evidence="8">
<location>
<begin position="701"/>
<end position="703"/>
</location>
</feature>
<feature type="helix" evidence="8">
<location>
<begin position="707"/>
<end position="717"/>
</location>
</feature>
<feature type="turn" evidence="4">
<location>
<begin position="718"/>
<end position="720"/>
</location>
</feature>
<feature type="helix" evidence="7">
<location>
<begin position="723"/>
<end position="726"/>
</location>
</feature>
<evidence key="1" type="ECO:0000244">
<source>
<dbReference type="PDB" id="3NY5"/>
</source>
</evidence>
<evidence key="2" type="ECO:0000244">
<source>
<dbReference type="PDB" id="3OG7"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000244">
<source>
<dbReference type="PDB" id="4E26"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000244">
<source>
<dbReference type="PDB" id="4RZV"/>
</source>
</evidence>
<evidence key="5" type="ECO:0000244">
<source>
<dbReference type="PDB" id="4RZW"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000244">
<source>
<dbReference type="PDB" id="4WO5"/>
</source>
</evidence>
<evidence key="7" type="ECO:0000244">
<source>
<dbReference type="PDB" id="5HID"/>
</source>
</evidence>
<evidence key="8" type="ECO:0000244">
<source>
<dbReference type="PDB" id="5ITA"/>
</source>
</evidence>
<evidence key="9" type="ECO:0000244">
<source>
<dbReference type="PDB" id="5JRQ"/>
</source>
</evidence>
<evidence key="10" type="ECO:0000244">
<source>
<dbReference type="PDB" id="5JSM"/>
</source>
</evidence>
<evidence key="11" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="16964243"/>
</source>
</evidence>
<evidence key="12" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="18669648"/>
</source>
</evidence>
<evidence key="13" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="21406692"/>
</source>
</evidence>
<evidence key="14" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="23186163"/>
</source>
</evidence>
<evidence key="15" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="24275569"/>
</source>
</evidence>
<evidence key="16" type="ECO:0000250"/>
<evidence key="17" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="P28028"/>
</source>
</evidence>
<evidence key="18" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00159"/>
</source>
</evidence>
<evidence key="19" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00226"/>
</source>
</evidence>
<evidence key="20" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00262"/>
</source>
</evidence>
<evidence key="21" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU10027"/>
</source>
</evidence>
<evidence key="22" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11410590"/>
</source>
</evidence>
<evidence key="23" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12068308"/>
</source>
</evidence>
<evidence key="24" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12198537"/>
</source>
</evidence>
<evidence key="25" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12460919"/>
</source>
</evidence>
<evidence key="26" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="14500344"/>
</source>
</evidence>
<evidence key="27" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="14612909"/>
</source>
</evidence>
<evidence key="28" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="1508179"/>
</source>
</evidence>
<evidence key="29" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16439621"/>
</source>
</evidence>
<evidence key="30" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16474404"/>
</source>
</evidence>
<evidence key="31" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16959974"/>
</source>
</evidence>
<evidence key="32" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17344846"/>
</source>
</evidence>
<evidence key="33" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18042262"/>
</source>
</evidence>
<evidence key="34" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18287029"/>
</source>
</evidence>
<evidence key="35" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18974108"/>
</source>
</evidence>
<evidence key="36" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19206169"/>
</source>
</evidence>
<evidence key="37" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19710016"/>
</source>
</evidence>
<evidence key="38" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21102438"/>
</source>
</evidence>
<evidence key="39" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21441910"/>
</source>
</evidence>
<evidence key="40" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21917714"/>
</source>
</evidence>
<evidence key="41" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="22628551"/>
</source>
</evidence>
<evidence key="42" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="23263490"/>
</source>
</evidence>
<evidence key="43" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="23907581"/>
</source>
</evidence>
<evidence key="44" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="24455489"/>
</source>
</evidence>
<evidence key="45" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="27353360"/>
</source>
</evidence>
<evidence key="46" type="ECO:0000269">
<source ref="8"/>
</evidence>
<evidence key="47" type="ECO:0000305"/>
<sequence length="766" mass="84437" checksum="0798C2AAB487E813" modified="2004-07-19" version="4">
MAALSGGGGGGAEPGQALFNGDMEPEAGAGAGAAASSAADPAIPEEVWNIKQMIKLTQEH
IEALLDKFGGEHNPPSIYLEAYEEYTSKLDALQQREQQLLESLGNGTDFSVSSSASMDTV
TSSSSSSLSVLPSSLSVFQNPTDVARSNPKSPQKPIVRVFLPNKQRTVVPARCGVTVRDS
LKKALMMRGLIPECCAVYRIQDGEKKPIGWDTDISWLTGEELHVEVLENVPLTTHNFVRK
TFFTLAFCDFCRKLLFQGFRCQTCGYKFHQRCSTEVPLMCVNYDQLDLLFVSKFFEHHPI
PQEEASLAETALTSGSSPSAPASDSIGPQILTSPSPSKSIPIPQPFRPADEDHRNQFGQR
DRSSSAPNVHINTIEPVNIDDLIRDQGFRGDGGSTTGLSATPPASLPGSLTNVKALQKSP
GPQRERKSSSSSEDRNRMKTLGRRDSSDDWEIPDGQITVGQRIGSGSFGTVYKGKWHGDV
AVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTKPQLAIVTQWCEGSSLYHH
LHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATV
KSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNIN
NRDQIIFMVGRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARS
LPKIHRSASEPSLNRAGFQTEDFSLYACASPKTPIQAGGYGAFPVH
</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
Distributed under the Creative Commons Attribution-NoDerivs License
</copyright>
</uniprot>